Behavioural syndromes associated with physiological disturbances and physical factors

F5_BEHAVE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints F5_ANOREX F5_BULIMIA F5_EATOTH F5_SLEEP F5_SEXDYS F5_MENTPUER F5_ABUNONDEP F5_PHYSBEHOTH	16116
6. Filter based on genotype QC (FinnGen only)	16116

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	F5_BEHAVE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	F5_ANOREX\|F5_BULIMIA\|F5_EATOTH\|F5_SLEEP\|F5_SEXDYS\|F5_MENTPUER\|F5_ABUNONDEP\|F5_PHYSBEHOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Behavioural syndromes associated with physiological disturbances and physical factors based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	132456	80403	51212
Only index persons	118006	73915	44091
Unadjusted period prevalence (%)
Whole population	1.96	2.30	1.43
Only index persons	2.33	2.72	1.68
Median age at first event (years)
Whole population	31.59	27.76	37.42
Only index persons	30.35	26.81	36.28

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	16116	10975	5141
Unadjusted period prevalence (%)	3.27	3.74	2.27
Median age at first event (years)	38.33	33.96	47.65

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
14143: Matched controls
141357

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F50.2

ICD-10 Finland

Bulimia nervosa

188.0

323.0

948

N06AB10

ATC

escitalopram; oral

3.0

323.0

4572

19449

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

5.6

323.0

1461

2830

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

19.9

323.0

1203

657

N05BA01

ATC

diazepam; systemic, rectal

3.4

323.0

2471

8344

78410

ICD-8 Finland

Symptoms referable to upper gastro-intestinal tract, Emesis

+∞

323.0

371

N05AH03

ATC

olanzapine; systemic

6.2

323.0

2100

3866

P06

ICPC

Sleep disturbance

3.3

323.0

2167

7416

N06AA12

ATC

doxepin; systemic

5.3

323.0

1076

2164

N06AB03

ATC

fluoxetine; oral

4.8

323.0

3415

8719

N06AB06

ATC

sertraline; oral

3.9

323.0

2864

8678

C07AA05

ATC

propranolol; systemic

2.4

323.0

3496

16812

N05CF02

ATC

zolpidem; oral

3.3

323.0

3510

12710

N03AG01

ATC

valproic acid; systemic, rectal

4.4

323.0

1518

3786

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

347.9

323.0

376

N06AX05

ATC

trazodone; oral

9.1

323.0

971

1135

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

5.2

323.0

1876

4075

G47.3

ICD-10 Finland

Sleep apnoea

2.6

323.0

3039

13514

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

8.7

323.0

1449

1836

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

6.0

323.0

1661

3069

F41.1

ICD-10 Finland

Generalized anxiety disorder

4.0

323.0

1481

4012

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

6.2

323.0

1115

1932

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

483.2

323.0

515

N05AH04

ATC

quetiapine; oral

6.5

323.0

5846

13742

N03AX09

ATC

lamotrigine; oral

5.0

323.0

1560

3423

N05AX12

ATC

aripiprazole; systemic

5.6

323.0

1391

2708

F50.3

ICD-10 Finland

Atypical bulimia nervosa

169.8

323.0

664

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.3

323.0

2471

8501

N05AA02

ATC

levomepromazine; systemic

7.4

323.0

1283

1880

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

5.3

323.0

2286

4983

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.7

323.0

3987

10975

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

5.0

323.0

2143

4852

N06AB04

ATC

citalopram; systemic

3.2

323.0

4170

16217

F50.1

ICD-10 Finland

Atypical anorexia nervosa

261.1

323.0

813

F50.8

ICD-10 Finland

Other eating disorders

165.1

323.0

571

F51.0

ICD-10 Finland

Nonorganic insomnia

11.5

323.0

6516

9809

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

4.0

323.0

2958

8799

F50.0

ICD-10 Finland

Anorexia nervosa

590.5

323.0

1095

F29

ICD-10 Finland

Unspecified nonorganic psychosis

5.0

323.0

1161

2490

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.0

323.0

1391

3011

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

4.1

323.0

2590

7316

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

13.4

323.0

978

782

N05CF01

ATC

zopiclone; oral

3.6

323.0

5638

22193

N05BA04

ATC

oxazepam; oral

3.9

323.0

5405

19555

N05CD07

ATC

temazepam; oral

4.1

323.0

2027

5499

N06AX16

ATC

venlafaxine; oral

4.0

323.0

3598

11110

N03AX16

ATC

pregabalin; oral

2.6

323.0

3544

16250

N05AX08

ATC

risperidone; systemic

4.5

323.0

1741

4293

3074A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]

+∞

323.0

547

N06AX12

ATC

bupropion; oral

4.3

323.0

1885

4901

N06AX03

ATC

mianserin; oral

6.2

323.0

1177

2024

N06AX11

ATC

mirtazapine; oral

4.9

323.0

7424

26015

F50.9

ICD-10 Finland

Eating disorder, unspecified

173.4

323.0

1615

105

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

4.2

323.0

3138

8905

N06AX21

ATC

duloxetine; oral

3.6

323.0

2268

7197

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.2

321.8

1081

2231

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

5.5

318.2

1010

1952

N03AE01

ATC

clonazepam; systemic

4.4

299.3

1190

2920

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

6.9

297.0

785

1197

N05AF03

ATC

chlorprothixene; systemic

6.5

296.7

817

1318

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

5.8

294.9

887

1603

F34.1

ICD-10 Finland

Dysthymia

5.1

293.7

998

2080

R53

ICD-10 Finland

Malaise and fatigue

2.3

291.9

3310

16566

N06AA06

ATC

trimipramine; systemic

7.9

290.2

695

915

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.2

280.4

1642

5555

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

8.0

279.8

666

868

N05BA12

ATC

alprazolam; oral

3.0

277.4

1761

6302

P29

ICPC

Psychological sympt/compl other

3.3

277.1

1554

5092

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

5.3

276.8

903

1795

P01

ICPC

Feeling anxious/nervous/tense

2.4

275.5

2733

12745

P76

ICPC

Depressive disorder

3.2

271.2

1571

5264

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

92.9

269.3

300

P86

ICPC

Anorexia nervosa/bulimia

34.9

264.9

348

102

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

261.1

5566

35868

N06AX26

ATC

vortioxetine; oral

3.4

258.6

1358

4222

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.6

258.5

1293

3868

SPAT1240

SPAT

Therapeutic discussion

2.4

253.6

2440

11145

N06AB05

ATC

paroxetine; oral

3.5

249.2

1267

3835

N05BA06

ATC

lorazepam; systemic, sublingual

4.5

244.4

942

2229

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

6.3

241.5

680

1125

IGY99

NOMESCO Finland

Other psychiatric treatment contact

5.8

233.9

702

1259

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

5.1

232.6

776

1576

N03AX12

ATC

gabapentin; oral

2.4

232.0

2209

9988

N06AA09

ATC

amitriptyline; systemic

3.1

231.9

1444

5064

F60.9

ICD-10 Finland

Personality disorder, unspecified

7.9

229.5

547

712

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

5.8

227.5

686

1237

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

227.1

3549

20088

N05BE01

ATC

buspirone; oral

5.6

226.5

704

1317

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

6.1

224.1

649

1112

P03

ICPC

Feeling depressed

2.4

223.4

2150

9756

IGY02

NOMESCO Finland

Psychiatric monitoring contact

5.1

219.5

741

1523

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

5.5

219.0

683

1282

N02AX02

ATC

tramadol; systemic, rectal

1.8

218.7

5105

33358

N05AB03

ATC

perphenazine; systemic, rectal

4.7

217.3

793

1771

F32.1

ICD-10 Finland

Moderate depressive episode

3.1

214.0

1331

4652

N06AX22

ATC

agomelatine; oral

5.5

213.9

667

1251

N05AN01

ATC

lithium; oral

5.4

211.3

677

1311

F61.0

ICD-10 Finland

Mixed personality disorders

6.3

206.8

581

956

A02BC02

ATC

pantoprazole; systemic

1.7

205.2

7980

60713

G47.9

ICD-10 Finland

Sleep disorder, unspecified

5.8

204.9

615

1101

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.8

204.4

1430

5391

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

18.9

203.0

318

172

F51

ICD-10 Finland

Nonorganic sleep disorders

4.0

200.5

867

2276

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.7

196.7

602

1103

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

4.6

192.5

709

1595

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

4.1

190.7

800

2041

P99

ICPC

Psychological disorders other

4.4

190.7

739

1749

R51.80

ICD-10 Finland

Headache

2.1

190.7

2600

13776

M79.6

ICD-10 Finland

Pain in limb

1.8

190.3

4685

30778

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

5.7

189.8

580

1060

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.4

189.7

995

3063

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

3.4

189.3

982

2997

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

4.9

188.4

650

1365

P74

ICPC

Anxiety disorder/anxiety state

3.3

187.7

1015

3197

F31.8

ICD-10 Finland

Other bipolar affective disorders

5.3

187.1

601

1165

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

276.1

186.3

190

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

181.2

2875

16147

N06AG02

ATC

moclobemide; oral

4.0

180.0

774

2018

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

7.3

179.3

452

639

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

7.1

179.0

459

665

Z71.8

ICD-10 Finland

Other specified counselling

1.8

177.9

3773

23494

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.3

176.5

699

1688

F32

ICD-10 Finland

Depressive episode

2.9

173.7

1141

4111

78419

ICD-8 Finland

Symptoms referable to upper gastro-intestinal tract, Nausea NUD

+∞

173.2

166

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

5.9

171.7

503

872

AA1AD

NOMESCO Finland

CT of head and brain

2.0

169.5

2591

14294

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

169.5

3006

17536

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

5.3

167.7

538

1040

78450

ICD-8 Finland

Symptoms referable to upper gastro-intestinal tract, Haematemesis

+∞

165.9

159

F99

ICD-10 Finland

Mental disorder, not otherwise specified

4.9

164.3

573

1215

R06.0

ICD-10 Finland

Dyspnoea

1.9

163.1

2975

17494

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

6.3

163.1

457

748

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

6.2

162.1

457

754

N04BC05

ATC

pramipexole; oral

3.1

161.5

965

3257

N07BB01

ATC

disulfiram; oral

3.5

159.0

813

2445

R42

ICD-10 Finland

Dizziness and giddiness

1.9

153.9

2548

14426

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

5.6

153.6

468

851

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

4.5

149.8

566

1303

G44.2

ICD-10 Finland

Tension-type headache

2.0

148.4

2061

10883

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

146.3

2627

15284

A06AD11

ATC

lactulose; oral

2.3

146.2

1562

7345

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

144.3

2765

16442

M54.5

ICD-10 Finland

Low back pain

1.7

144.1

4426

30422

N05AD01

ATC

haloperidol; systemic

4.6

143.8

525

1167

F53.0

ICD-10 Finland

Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified

50.3

143.1

174

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.7

142.5

669

1875

N06AB08

ATC

fluvoxamine; oral

4.5

139.8

527

1209

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

5.0

138.0

466

953

A02BC01

ATC

omeprazole; systemic

1.7

137.8

3275

20834

L03

ICPC

Low back symptom/complaint

1.7

136.6

3313

21199

A04

ICPC

Weakness/tiredness general

2.0

135.8

2008

10834

C07AB07

ATC

bisoprolol; oral

1.6

135.1

4437

30926

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.9

135.0

885

3170

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

134.5

5701

42408

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

133.2

4614

32586

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.4

133.2

1258

5557

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.1

133.1

440

879

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.4

131.4

1221

5343

3071A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Anorexia nervosa

+∞

131.4

126

IER01

NOMESCO Finland

Psychoeducation, group

9.8

131.4

274

284

E66.8

ICD-10 Finland

Other obesity

2.8

130.8

927

3485

IBZ05

NOMESCO Finland

Evaluation of patient with eating disorder

330.0

130.7

132

N02BE01

ATC

paracetamol; systemic, rectal

1.6

129.4

11146

97943

R11

ICD-10 Finland

Nausea and vomiting

2.3

128.0

1266

5718

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

127.9

3144

20132

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

6.8

127.5

335

502

SPAT1307

SPAT

Psychosocial counselling and guidance

2.2

126.3

1494

7332

A02BC05

ATC

esomeprazole; systemic

1.6

124.6

4670

33507

N91.1

ICD-10 Finland

Secondary amenorrhoea

3.9

123.5

548

1462

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

4.6

122.6

453

1018

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.0

122.5

1889

10321

F51.8

ICD-10 Finland

Other nonorganic sleep disorders

11.4

122.0

235

209

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

6.2

120.5

339

557

F39

ICD-10 Finland

Unspecified mood [affective] disorder

4.1

120.3

491

1215

F41.8

ICD-10 Finland

Other specified anxiety disorders

3.3

119.9

651

2042

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

119.8

3417

22765

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

119.7

1820

9888

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

4.4

119.0

452

1044

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

4.6

119.0

431

949

L17

ICPC

Foot/toe symptom/complaint

1.7

118.0

3139

20495

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.2

117.8

669

2168

N03AX11

ATC

topiramate; oral

3.6

117.1

566

1622

R03AC02

ATC

salbutamol; inhalant

1.5

117.0

6999

55718

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

116.8

4735

34489

A02BC03

ATC

lansoprazole; oral

1.7

116.7

3140

20555

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

116.5

3123

20419

F40.1

ICD-10 Finland

Social phobias

3.4

116.2

600

1812

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.1

114.9

384

776

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.6

114.2

917

3701

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.9

113.4

726

2554

N06BA04

ATC

methylphenidate; oral

3.3

113.3

607

1885

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

376.9

112.5

113

F53.1

ICD-10 Finland

Severe mental and behavioural disorders associated with the puerperium, not elsewhere classified

288.9

112.1

114

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.3

112.1

361

700

R4110

NOMESCO Finland

Physiotherapy

1.7

112.0

3080

20248

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.7

111.7

845

3297

N05AH02

ATC

clozapine; systemic

4.2

110.1

438

1058

A01

ICPC

Pain general/multiple sites

2.4

109.5

1044

4613

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

189.7

108.5

113

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

108.5

9972

86427

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

107.7

2201

13217

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

107.2

1334

6666

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

5.4

106.5

333

624

N05BA02

ATC

chlordiazepoxide; systemic

4.5

106.4

393

883

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

106.0

2128

12698

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

105.6

4120

29556

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

105.2

3239

21895

R02

ICPC

Shortness of breath/dyspnoea

2.0

105.2

1495

7882

P15

ICPC

Chronic alcohol abuse

3.7

103.7

476

1306

F32.8

ICD-10 Finland

Other depressive episodes

4.5

103.7

383

860

K59.09

ICD-10 Finland

Constipation, unspecified

2.7

103.7

747

2827

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

103.6

2187

13253

R06.5

ICD-10 Finland

Mouth breathing

2.2

102.8

1128

5324

WX110

NOMESCO Finland

Local anesthesy

1.5

102.6

9551

82370

R5140

NOMESCO Finland

Monitoring the use of the aid

2.2

102.5

1161

5561

D01

ICPC

Abdominal pain/cramps general

1.9

102.2

1741

9816

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

7.0

101.5

260

376

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

101.4

2093

12583

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

4.4

101.3

384

885

AA400

NOMESCO Finland

Electroconvulsive therapy

7.3

101.3

253

353

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.1

101.2

412

1017

K59.0

ICD-10 Finland

Constipation

2.7

100.8

735

2802

S18

ICPC

Laceration/cut

1.5

100.8

4636

34451

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

5.5

100.0

309

571

A02BA02

ATC

ranitidine; systemic

1.8

99.5

1995

11874

N04AA02

ATC

biperiden; systemic

4.5

99.2

367

826

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

99.1

1640

9141

J01DB01

ATC

cefalexin; oral

1.5

98.5

11017

98361

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.5

98.2

805

3281

M25.5

ICD-10 Finland

Pain in joint

1.6

97.8

3563

25047

R4190

NOMESCO Finland

Nutritional therapy

3.0

97.6

610

2109

L01

ICPC

Neck symptom/complaint

1.8

97.5

1861

10895

L28

ICPC

Limited function/disability (L)

1.9

97.0

1507

8205

H03AA01

ATC

levothyroxine sodium; systemic

1.6

96.7

2723

17911

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

96.6

938

4177

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

96.5

2325

14630

M03BX02

ATC

tizanidine; oral

1.4

96.0

7723

64182

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

96.0

7241

59421

78400

ICD-8 Finland

Symptoms referable to upper gastro-intestinal tract, Anorexia

+∞

95.9

D11

ICPC

Diarrhoea

1.8

95.8

1790

10403

N03AF01

ATC

carbamazepine; oral, rectal

2.8

95.4

654

2399

F52.2

ICD-10 Finland

Failure of genital response

6.3

95.1

264

427

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

95.0

5547

43210

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

94.9

2004

12109

F33

ICD-10 Finland

Recurrent depressive disorder

3.6

94.6

457

1308

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

94.5

1220

6177

F41.00

ICD-10 Finland

Moderate panic disorder

3.9

94.4

409

1068

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

94.0

1591

8929

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

93.4

6569

53052

C03CA01

ATC

furosemide; systemic

1.7

93.3

2184

13615

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

92.6

2232

14033

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

92.1

1229

6300

N05AA01

ATC

chlorpromazine; systemic, rectal

5.5

91.6

283

523

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

7.0

91.4

235

342

R52.9

ICD-10 Finland

Pain, unspecified

2.1

90.8

1083

5297

R52.2

ICD-10 Finland

Other chronic pain

3.1

90.8

527

1732

UJF32

NOMESCO Finland

Coloscopy

1.6

90.4

2571

16911

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

90.3

2334

14957

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

89.8

1051

5097

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

6.2

89.0

248

403

SPAT1234

SPAT

Support of social functional capacity

2.8

88.9

606

2213

F60.5

ICD-10 Finland

Anankastic personality disorder

5.3

88.6

282

540

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

87.8

1465

8167

F31

ICD-10 Finland

Bipolar affective disorder

4.8

87.6

303

636

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

86.6

3019

20891

S06.0

ICD-10 Finland

Concussion

1.9

86.5

1421

7876

IBA03

NOMESCO Finland

Psychotherapy evaluation

5.5

86.2

268

499

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.8

85.6

378

1004

P01AB01

ATC

metronidazole; oral, rectal

1.5

85.4

4820

37048

F50

ICD-10 Finland

Eating disorders

36.9

85.4

110

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

84.8

2335

15195

IEY01

NOMESCO Finland

Psychoeducation, individual

6.2

84.5

236

385

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

84.2

2401

15770

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

83.6

3144

22118

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

6.6

83.2

222

341

F51.1

ICD-10 Finland

Nonorganic hypersomnia

31.0

82.8

111

RD210

NOMESCO Finland

3.7

82.7

386

1074

N06AA04

ATC

clomipramine; systemic

4.6

82.6

303

676

F50.5

ICD-10 Finland

Vomiting associated with other psychological disturbances

213.6

82.4

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

81.9

855

3934

A28

ICPC

Limited function/disability NOS

2.0

81.3

1209

6454

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

5.7

81.1

244

437

M79.1

ICD-10 Finland

Myalgia

1.7

81.1

1728

10430

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

6.8

81.0

212

317

G43.9

ICD-10 Finland

Migraine, unspecified

2.1

80.3

1040

5258

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.9

80.0

343

888

N05CD02

ATC

nitrazepam; oral

5.5

79.4

246

457

F93.89

ICD-10 Finland

Other childhood emotional disorders

4.4

79.3

301

695

R55

ICD-10 Finland

Syncope and collapse

2.0

79.2

1141

6017

SPAT1260

SPAT

Consultation of another employee

1.6

79.1

2184

14193

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.6

78.9

382

1095

SPAT1254

SPAT

Administration of medicine

1.7

78.9

1902

11904

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

5.8

78.8

231

401

F41.3

ICD-10 Finland

Other mixed anxiety disorders

3.8

78.5

351

942

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.8

78.3

1603

9549

F51.3

ICD-10 Finland

Sleepwalking [somnambulism]

74.7

78.2

F33.8

ICD-10 Finland

Other recurrent depressive disorders

5.8

77.6

229

401

J01FF01

ATC

clindamycin; systemic

1.5

77.5

3131

22324

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

77.2

1326

7451

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

77.2

2166

14126

29440

ICD-8 Finland

Psychosis associated with other physical conditions, Childbirth

+∞

77.1

N01

ICPC

Headache

1.7

77.0

1922

12139

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

76.7

6631

54822

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

76.4

1620

9749

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

76.4

2247

14834

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

76.2

1876

11801

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

7.3

76.1

188

259

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

75.8

1607

9671

N05AL01

ATC

sulpiride; systemic

4.8

75.7

263

555

G03DB01

ATC

dydrogesterone; oral

1.7

75.5

1762

10909

N05AF01

ATC

flupentixol; systemic

4.6

75.1

271

595

SPAT1310

SPAT

Counselling related to known health issue

1.4

74.5

4146

31559

N06AX18

ATC

reboxetine; oral

5.5

74.4

229

422

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

11.8

74.3

140

120

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

74.2

1600

9674

T82

ICPC

Obesity

2.6

74.1

587

2343

R00.2

ICD-10 Finland

Palpitations

2.0

73.6

955

4827

H02AB06

ATC

prednisolone; systemic

1.4

72.5

5231

41737

N05AE04

ATC

ziprasidone; systemic

6.0

72.5

208

352

K59.1

ICD-10 Finland

Functional diarrhoea

2.4

72.0

652

2794

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

72.0

2201

14650

P72

ICPC

Schizophrenia

3.8

71.9

319

851

T05

ICPC

Feeding problem of adult

5.5

71.6

220

405

E66.9

ICD-10 Finland

Obesity, unspecified

2.6

71.3

551

2165

EBA00

NOMESCO Finland

Extraction of tooth

1.4

71.1

4366

33792

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

71.0

4154

31859

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

70.9

3935

29872

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.2

70.8

284

692

K02.1

ICD-10 Finland

Caries of dentine

1.4

70.7

7923

68049

F10.24

ICD-10 Finland

Alcohol depence active use

4.4

70.6

265

606

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

5.5

70.2

215

394

F51.4

ICD-10 Finland

Sleep terrors [night terrors]

125.6

69.9

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

69.8

4164

32027

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

69.7

2320

15760

M79.7

ICD-10 Finland

Fibromyalgia

2.7

69.4

504

1913

N05AB01

ATC

dixyrazine; systemic

5.5

68.8

211

388

IGV01

NOMESCO Finland

Psychiatric network contact

5.0

68.7

230

467

R50.9

ICD-10 Finland

Fever, unspecified

1.7

68.5

1718

10835

P18

ICPC

Medication abuse

7.0

68.3

174

251

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

68.3

2671

18827

R4140

NOMESCO Finland

Psychotherapy

5.6

68.0

207

377

S29

ICPC

Skin symptom/complaint other

1.6

68.0

1917

12479

R74

ICPC

Upper respiratory infection acute

1.4

68.0

4432

34612

N17

ICPC

Vertigo/dizziness

1.8

67.6

1231

7042

F60.8

ICD-10 Finland

Other specific personality disorders

6.2

67.5

189

310

SPAT1243

SPAT

Psychiatric/psychological examination

2.4

67.4

585

2449

R05

ICPC

Cough

1.5

67.2

2801

20010

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.9

67.2

1008

5382

N30.0

ICD-10 Finland

Acute cystitis

1.7

67.0

1726

10963

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

66.8

4971

39705

J02AC01

ATC

fluconazole; systemic

1.4

66.8

5129

41192

3160A

ICD-9 Finland

Psychic factors associated with diseases classified elsewhere[PSYYK TEKIJÄT ORGAANISTEN SAIRAUKSIEN/OIREIDEN YHTE]

+∞

66.7

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

66.6

1199

6830

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

66.4

1012

5436

K30

ICD-10 Finland

Functional dyspepsia

1.8

66.3

1216

6967

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

66.3

1136

6363

KMAK

NOMESCO Finland

1.4

66.2

6982

59067

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

66.1

754

3602

L02

ICPC

Back symptom/complaint

1.8

66.1

1264

7342

R06AE07

ATC

cetirizine; oral

1.4

66.0

5702

46683

R63.0

ICD-10 Finland

Anorexia

11.0

65.9

128

117

UKC02

NOMESCO Finland

Cystoscopy

1.7

65.9

1377

8228

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

6.6

65.9

175

268

E87.6

ICD-10 Finland

Hypokalaemia

3.3

65.7

353

1097

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

6.2

65.7

182

295

R41.0

ICD-10 Finland

Disorientation, unspecified

3.6

65.6

314

893

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

6.9

65.5

168

245

Z00.0

ICD-10 Finland

General medical examination

1.5

65.4

2258

15443

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

6.9

65.3

168

246

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

6.1

65.1

183

302

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.9

64.9

996

5360

T90

ICPC

Diabetes non-insulin dependent

1.6

64.9

1891

12403

E0000UV

ATC

1.4

64.8

5007

40186

R63.4

ICD-10 Finland

Abnormal weight loss

3.0

64.8

404

1393

F21

ICD-10 Finland

Schizotypal disorder

6.6

64.7

171

260

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

64.7

7152

60867

E66.00

ICD-10 Finland

Metabolic syndrome

2.3

64.7

612

2680

SPAT1301

SPAT

No procedures

1.4

64.7

3774

28814

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

8.7

64.6

143

166

78440

ICD-8 Finland

Symptoms referable to upper gastro-intestinal tract, Dysphagia

+∞

64.6

R4120

NOMESCO Finland

Occupational therapy

2.1

64.5

770

3750

F52.0

ICD-10 Finland

Lack or loss of sexual desire

16.3

64.2

105

C07AB02

ATC

metoprolol; systemic

1.6

64.0

1691

10805

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.0

63.8

394

1350

R5599

NOMESCO Finland

Other rehabilitation service

2.9

63.7

399

1380

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

63.6

3965

30619

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

6.0

63.5

181

304

Z01.7

ICD-10 Finland

Laboratory examination

1.7

63.4

1314

7827

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

63.3

2248

15463

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

5.7

63.3

188

333

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

63.1

2982

21827

N02AA05

ATC

oxycodone; systemic

1.8

63.1

1232

7201

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

62.7

945

5053

N05AC02

ATC

thioridazine; oral

3.3

62.3

331

1021

SPAT1216

SPAT

Assessment of functional ability

1.7

62.3

1359

8221

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

5.4

62.2

195

368

A03FA02

ATC

cisapride; oral, rectal

2.1

62.2

781

3888

M01AB05

ATC

diclofenac; systemic, rectal

1.3

62.1

7811

67632

N05AD03

ATC

melperone; systemic

5.3

62.1

198

381

WX290

NOMESCO Finland

Other blockade of nerve

1.3

62.1

6396

53681

J01MA02

ATC

ciprofloxacin; systemic

1.4

62.0

4008

31124

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

61.9

1092

6171

P16

ICPC

Acute alcohol abuse

3.7

61.8

285

786

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

61.7

3264

24417

J01DA01

ATC

[U] cefalexin; systemic

1.3

61.6

7727

66835

J01AA02

ATC

doxycycline; systemic

1.4

61.2

9084

80626

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

60.8

972

5305

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

60.7

1347

8184

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

60.7

1210

7114

XA800

NOMESCO Finland

Neuropsychological investigation

2.3

60.6

573

2507

R35

ICD-10 Finland

Polyuria

2.2

60.4

625

2854

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

6.4

60.2

164

260

L08

ICPC

Shoulder symptom/complaint

1.6

60.1

1903

12723

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.5

59.7

496

2030

-1

NOMESCO Finland

1.4

59.7

4823

38853

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

59.4

3013

22328

A10BA02

ATC

metformin; oral

1.5

59.2

2322

16311

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

59.2

867

4585

R07.3

ICD-10 Finland

Other chest pain

1.9

58.6

971

5369

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

14327

121799

2.58

316.36

6.3

4.6

2.3

2.1

mu/l

0.36

13583

113982

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8395

59440

1.86

311.89

5.7

10.2

10.9

umol/l

6.83

7885

56003

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2810

13554

2.30

310.16

6.7

6.1

1.1

mmol/l

6.67

2601

12745

(3018418) pH of Serum or Plasma

5401

31318

2.09

307.65

4.4

3.9

7.4

1.80

904

6132

(3024561) Albumin [Mass/volume] in Serum or Plasma

7337

47368

2.01

307.65

4.9

4.8

36.7

36.3

g/l

6.76

6783

44107

(3021960) Folate [Moles/volume] in Serum or Plasma

4486

23830

2.22

307.65

1.6

1.5

20.7

20.2

nmol/l

1.59

4049

20833

(3011288) Drugs identified in Urine by Screen method

1751

6426

2.93

307.65

3.8

2.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7263

43531

2.21

307.65

2.2

1.8

98.1

97.0

pmol/l

1.06

3942

23561

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6674

41875

2.01

307.65

3.6

3.1

30.4

32.2

u/l

0.91

6341

39858

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8427

53638

2.19

307.65

7.4

6.3

1.2

mmol/l

1.87

7261

45434

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7734

48236

2.16

307.65

6.7

5.7

1.2

mmol/l

1.60

7156

44011

(3015377) Calcium [Moles/volume] in Serum or Plasma

6404

36555

2.25

307.65

2.9

3.2

2.4

2.3

mmol/l

0.32

5735

32386

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7879

51072

2.06

307.65

2.7

2.2

73.5

1813.7

nmol/l

0.50

7299

47139

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

13120

104553

2.37

307.65

5.1

4.0

14.3

14.5

pmol/l

18.10

12276

96329

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

12079

91838

2.26

307.65

7.8

6.9

75.1

75.6

u/l

0.60

11489

86539

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

4067

18740

2.56

307.65

2.2

1.7

1.5

1.4

22.38

3661

16827

(3028707) Methadone [Presence] in Urine by Screen method

1487

3852

4.15

307.65

3.1

2.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

3555

17548

2.31

307.65

1.9

1.7

1183.0

1169.0

nmol/l

0.37

2845

13525

(3001122) Ferritin [Mass/volume] in Serum or Plasma

9024

65813

1.84

299.96

3.6

2.9

84.6

92.7

ug/l

3.60

8476

62026

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5775

36816

1.88

294.73

3.3

2.5

56.8

57.3

u/l

0.16

5332

34099

(1001926) Buprenorphine [Presence] in Urine by Screen method

1814

7324

2.66

293.99

2.9

2.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

9828

73970

1.84

290.70

10.3

8.6

4.0

e9/l

0.08

8617

64945

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4945

30376

1.90

280.04

2.5

2.2

2.7

2.8

mg/l

0.17

4249

26142

(3013115) Eosinophils [#/volume] in Blood

9063

66985

1.80

279.94

7.2

6.1

0.2

e9/l

0.71

8023

59603

(3006315) Basophils [#/volume] in Blood

8819

64657

1.80

279.91

6.8

5.9

0.0

e9/l

0.38

7693

56581

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2504

11974

2.29

279.70

2.0

2.1

374.1

377.6

nmol/l

0.38

2282

11033

(3001604) Monocytes [#/volume] in Blood

8792

64419

1.80

279.45

6.8

5.9

0.6

e9/l

1.45

7662

56450

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5068

31464

1.89

277.17

2.6

2.1

210.2

196.9

u/l

0.26

4776

29710

(3013826) Glucose [Moles/volume] in Serum or Plasma

9310

69529

1.80

275.93

5.8

4.4

6.5

mmol/l

0.01

8693

63202

(3009466) Valproate [Moles/volume] in Serum or Plasma

717

1693

4.38

274.80

6.1

5.2

379.9

371.7

umol/l

0.71

634

1472

(3019550) Sodium [Moles/volume] in Serum or Plasma

14703

128474

2.64

271.00

18.8

12.2

139.4

139.6

mmol/l

16.34

14435

124911

(3016879) Cocaine [Presence] in Urine

1989

8738

2.45

268.88

2.9

2.0

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3194

17082

2.08

267.81

3.5

3.6

0.8

mmol/l

0.16

2936

16044

(3023103) Potassium [Moles/volume] in Serum or Plasma

14713

128844

2.62

265.43

18.9

12.3

3.9

mmol/l

1.39

14410

124972

(3019198) Lymphocytes [#/volume] in Blood

9006

67054

1.78

265.04

6.8

5.8

2.0

e9/l

0.31

8004

59931

(3013707) Erythrocyte sedimentation rate by Westergren method

11614

93416

1.87

262.06

4.3

3.8

10.3

10.2

mm/h

0.56

10930

87215

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

507

943

5.51

257.86

13.1

11.9

0.6

mmol/l

0.02

469

869

(3000764) Benzodiazepines [Presence] in Urine

2064

9468

2.35

252.29

2.9

2.0

—

(3028300) Cannabinoids [Presence] in Urine

2068

9554

2.33

248.43

2.9

2.0

—

(3044889) 12 lead EKG panel

10257

80130

1.77

247.10

3.9

3.1

—

(3027008) Opiates [Presence] in Urine

2054

9532

2.32

243.91

2.8

1.9

—

(42870588) Differential panel, method unspecified - Blood

6232

42466

1.76

242.99

6.3

6.0

—

(3022096) Basophils/100 leukocytes in Blood

7953

58677

1.70

227.59

6.9

6.1

0.7

0.40

7453

54921

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5233

34426

1.77

226.84

1.5

1.3

1.6

1.7

u/ml

0.20

1345

9623

(3019069) Monocytes/100 leukocytes in Blood

8206

61091

1.70

226.71

7.1

6.2

8.2

8.3

1.24

7735

57521

(3009508) Creatinine [Moles/volume] in Urine

5132

33599

1.77

226.04

3.6

3.2

7.7

8.0

mmol/l

3.06

4404

28930

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3225

18288

1.95

224.82

2.5

2.8

2.4

mmol/l

6.83

2784

15893

(3006504) Eosinophils/100 leukocytes in Blood

8160

60750

1.69

224.61

6.9

6.0

2.7

2.8

3.15

7646

56843

(3027944) Amphetamines [Presence] in Urine

1987

9400

2.27

224.33

2.9

1.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

11247

91578

1.75

219.68

4.1

2.9

41.0

40.0

u/l

0.72

10661

86899

(3022948) Iron [Moles/volume] in Serum or Plasma

3127

17756

1.94

216.15

2.7

2.4

14.0

13.9

umol/l

0.12

2917

16550

(3002030) Lymphocytes/100 leukocytes in Blood

8411

63646

1.67

213.13

6.9

5.9

29.4

29.3

0.54

7918

59699

(3018010) Neutrophils/100 leukocytes in Blood

8306

62726

1.67

211.42

6.8

5.8

56.2

56.4

0.86

7825

59053

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

5979

41578

1.69

207.67

3.8

3.1

—

0.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2866

16180

1.94

199.87

2.7

2.4

g/l

1.68

2630

15051

(3007164) IgA [Mass/volume] in Serum or Plasma

4529

29528

1.74

196.89

1.5

1.4

2.1

2.2

g/l

1.73

2617

18713

(3031040) Bacteria [#/volume] in Urine by Automated count

10617

86233

1.68

196.75

5.4

4.0

1448.9

1490.9

e6/l

0.02

164

1057

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1985

9866

2.15

196.69

2.6

2.4

0.2

g/l

5.01

1820

9222

(40758558) Short blood count panel - Blood

4724

31239

1.72

194.74

7.4

6.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

13709

119916

1.95

194.50

4.8

3.7

5.8

5.7

mmol/l

12.04

12791

111437

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3678

22722

1.80

191.87

1.7

1.6

22000442.0

31626512.8

pmol/l

0.57

3150

19427

(3018095) Leukocytes [#/volume] in Urine

6084

43350

1.65

187.05

4.4

3.4

75.8

84.0

e6/l

0.29

4257

29226

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

501

1210

4.24

185.86

2.1

1.9

—

(3002582) Erythrocytes [#/volume] in Urine

5139

35423

1.66

177.77

3.8

3.0

77.0

75.0

e6/l

0.03

3960

26779

(3030467) Casts [#/volume] in Urine by Automated count

4762

32243

1.68

176.17

3.6

2.9

0.3

0.4

e6/l

2.39

3592

23904

(3037467) Urinalysis macro (dipstick) panel - Urine

10885

90298

1.63

172.40

5.0

4.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2591

14804

1.89

171.67

2.8

2.5

23.1

23.5

0.94

2275

12776

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5524

39051

1.63

171.33

4.3

3.0

54.2

62.7

ng/l

0.16

3193

21440

(36304419) Bacteria [Presence] in Urine

4699

32031

1.66

167.70

3.5

2.9

—

(3033658) Prothrombin time (PT) actual/Normal

4428

29792

1.67

165.90

4.4

3.8

94.1

93.1

2.04

4287

28981

(3021589) Normoblasts [#/volume] in Blood

7538

57689

1.57

165.48

10.4

8.6

0.0

e9/l

1.50

6126

47367

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1828

9482

2.05

159.73

5.2

4.2

5.9

5.8

kpa

5.28

1774

9188

(44816559) Phosphatidylethanol [Mass/volume] in Blood

795

2864

2.87

157.70

1.5

1.4

—

(3026782) Osmolality of Urine

3532

22641

1.72

157.38

3.0

2.6

525.7

551.4

mosm/kgh2o

8.32

2967

19281

(3002032) Base excess in Venous blood by calculation

1815

9441

2.04

157.23

5.3

4.2

1.7

1.8

mmol/l

0.08

1498

7584

(3012544) pH of Venous blood

1856

9771

2.02

155.38

5.2

4.2

7.4

0.86

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

12561

109311

1.67

151.58

5.9

4.7

38.8

38.3

mmol/mol

5.44

11790

102767

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

13416

118853

1.76

151.49

14.4

10.2

91.2

90.0

ml/min/173m2

7.12

11004

96293

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2020

11071

1.94

150.24

2.9

2.5

32.4

42.8

u/l

1.54

1719

9508

(4198724)

393

941

4.25

147.34

3.3

2.2

—

(3000850) Epithelial cells [#/volume] in Urine

3712

24494

1.67

146.85

2.9

2.5

7.2

6.8

e6/l

0.79

3238

21372

(3024354) Oxygen [Partial pressure] in Venous blood

1545

7803

2.08

144.40

4.6

3.7

4.8

4.7

kpa

1.03

1493

7544

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15072

139182

2.27

143.85

11.9

8.9

26.7

26.1

u/l

1.20

14708

134774

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

14618

133514

2.01

142.76

17.2

11.4

19.8

21.4

mg/l

8.51

11698

103147

(3020564) Creatinine [Moles/volume] in Serum or Plasma

14964

137850

2.19

142.74

18.2

12.5

73.8

72.3

umol/l

4.94

14957

137788

(3019150) Specific gravity of Urine by Refractometry

4111

28104

1.62

140.23

4.2

3.5

1.0

kg/l

2.16

516

4182

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4098

28178

1.61

135.69

2.1

1.8

0.9

1.1

mg/l

1.29

2934

20901

(3014111) Lactate [Moles/volume] in Serum or Plasma

1657

8793

1.98

134.55

7.0

7.3

1.4

1.3

mmol/l

0.32

1572

8464

(3048689) Calprotectin [Mass/mass] in Stool

3020

19275

1.70

133.92

2.3

2.5

93.9

117.6

ug/g

4.68

2340

15173

(3014576) Chloride [Moles/volume] in Serum or Plasma

2119

12215

1.84

133.75

7.0

7.1

104.2

104.7

mmol/l

5.09

2062

11975

(3023368) Bacteria identified in Blood by Culture

4028

27771

1.60

131.10

5.0

4.0

—

(40768797) Stomach Pathology biopsy report

2514

15420

1.75

128.24

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3030

19663

1.66

125.11

4.0

3.3

217.5

499.5

ng/l

3.31

1921

12805

(3026008) Bacteria identified in Urine by Culture

4916

35811

1.54

124.19

3.4

2.6

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

378

1003

3.83

123.05

19.0

18.7

1366.0

2366.8

nmol/l

0.53

364

967

(3000991) Gas panel - Venous blood

1605

8737

1.93

120.26

8.9

8.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1129

5415

2.17

119.93

5.9

4.6

24.2

24.1

mmol/l

0.71

1020

4928

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

279

601

4.70

119.57

3.2

2.2

154.7

161.1

umol/l

0.11

142

302

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2677

17005

1.69

119.31

2.0

1.8

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

364

963

3.84

118.99

14.4

13.2

776.9

833.4

nmol/l

1.35

354

930

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2953

19260

1.65

118.83

3.1

2.6

1.1

e6/l

0.10

1621

10642

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3520

23998

1.60

118.14

3.2

2.9

1217.0

1151.2

ng/l

0.27

2852

20047

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2812

18169

1.66

117.21

3.3

2.7

4.1

3.4

e6/l

1.96

1477

9578

(3021387) Prolactin [Units/volume] in Serum or Plasma

1535

8308

1.94

116.84

1.7

1.6

371.8

312.7

mu/l

3.91

1349

7454

(3011397) Hemoglobin [Presence] in Urine by Test strip

4147

29454

1.55

116.03

3.9

3.3

—

(3032080) INR in Blood by Coagulation assay

5455

41113

1.49

115.01

7.9

7.2

1.1

1.2

inr

2.28

1757

12979

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1920

11224

1.81

114.52

1.9

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

7974

64764

1.46

114.20

4.1

3.3

0.0

estimate

1.91

1496

12668

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1923

11342

1.79

111.09

2.0

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2197

13498

1.73

109.94

2.6

2.8

6.4

7.3

umol/l

1.58

1796

11568

(3009261) Glucose [Presence] in Urine by Test strip

7998

65471

1.44

106.92

4.1

3.3

0.0

estimate

0.02

1505

12764

(3021601) Nitrite [Presence] in Urine by Test strip

7938

64933

1.44

106.28

5.5

4.4

0.0

estimate

0.16

1553

13090

(3002385) Erythrocyte distribution width [Ratio]

12781

114909

1.54

101.39

20.9

13.8

13.5

0.72

12585

112616

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

229

483

4.79

100.70

2.2

2.4

150.5

153.4

nmol/l

0.14

210

412

(36660697) Celiac disease serology panel - Serum

1999

12255

1.72

100.12

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4081

29706

1.50

98.81

1.7

1.6

1.4

mmol/l

4.52

3556

25674

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1541

8808

1.83

98.14

2.6

2.1

11.9

11.3

nmol/l

1.52

1351

7810

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1257

6767

1.93

96.47

4.5

3.8

5.2

5.1

kpa

4.26

1180

6295

(3009343) pH of Capillary blood

1243

6690

1.93

95.43

4.5

3.8

7.4

0.81

146

822

(3009214) Lutropin [Units/volume] in Serum or Plasma

1128

5875

1.99

95.33

1.6

1.4

8.2

9.2

u/l

2.28

881

4823

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1211

6487

1.94

94.26

4.4

3.7

1.6

1.4

mmol/l

1.36

886

4615

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1569

9124

1.80

94.18

3.1

3.4

4.4

4.6

pmol/l

7.96

1363

8234

(3003396) Base excess in Arterial blood by calculation

1779

10755

1.73

93.27

7.3

7.5

1.2

0.9

mmol/l

2.50

1440

8205

(3042936) Bacteria identified in Isolate by Culture

2434

15998

1.61

92.48

2.2

1.9

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1773

10740

1.73

92.24

7.3

7.4

12.1

13.1

kpa

14.19

1690

10251

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1773

10746

1.73

92.04

7.3

7.5

5.2

5.0

kpa

4.28

1695

10254

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1380

7787

1.84

91.33

1.7

1.6

—

(3000494) Fungus identified in Specimen by Culture

2170

13941

1.64

90.25

1.5

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

698

3091

2.31

89.56

1.4

307.2

287.7

ug/g

0.79

376

1698

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4241

31695

1.46

87.92

2.7

2.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1524

8977

1.77

87.23

8.6

7.8

8.1

8.5

mmol/l

1.75

1464

8606

(40761511) CBC panel - Blood by Automated count

14918

140382

1.83

87.04

15.7

10.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2455

16468

1.58

84.90

2.6

2.3

29.4

29.6

1.14

2367

15978

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

13623

125438

1.55

84.46

4.7

4.0

2.7

2.8

mmol/l

19.60

12719

117719

(3037522) Nuclear Ab [Titer] in Serum

2738

18861

1.54

84.06

1.4

458.0

551.3

titre

1.88

447

3723

(3016502) Oxygen saturation in Arterial blood

1576

9505

1.73

82.80

7.7

7.9

95.2

96.0

3.31

1535

9124

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1294

7376

1.82

82.54

4.6

4.0

90.9

84.5

ng/l

1.28

1132

6526

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3865

28743

1.45

81.01

2.5

2.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1757

10977

1.67

80.87

3.0

2.8

1.7

0.53

1511

9817

(3042517) Benzodiazepines panel - Urine

137

224

6.16

79.70

2.5

2.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

339

1112

3.09

79.19

1.9

1.5

1.3

1.4

promille

0.78

250

851

(3004119) Hemoglobin [Mass/volume] in Venous blood

1060

5771

1.89

78.11

4.1

3.6

131.2

130.5

g/l

0.42

1039

5634

(3007853) Bacteria identified in Skin by Aerobe culture

2214

14777

1.58

77.62

2.0

1.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

522

2165

2.46

77.55

2.3

3.0

31.3

34.4

umol/l

1.89

446

1863

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

13439

124069

1.50

75.15

4.3

3.7

4.6

4.7

mmol/l

25.17

12618

117233

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

13350

123210

1.48

73.49

4.3

3.7

1.4

1.5

mmol/l

6.26

12491

116050

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1036

5718

1.87

73.04

1.8

1.6

—

(3012516) Albumin [Mass/volume] in Urine

3701

27791

1.43

72.19

3.5

3.4

452.9

430.4

mg/l

0.10

2398

18031

(3052851) Hemolysis interference index of Serum or Plasma

692

3353

2.11

70.89

2.9

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

835

4341

1.97

70.46

4.1

3.2

0.7

0.01

811

4165

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1141

6576

1.79

69.76

1.6

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1068

6036

1.82

69.69

1.6

3.2

3.6

mg/l

1.13

856

4018

(1002224) Polysomnography panel

1027

5745

1.84

69.28

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3829

29123

1.41

68.94

4.3

4.1

10.3

10.2

mg/mmol

0.02

2477

19039

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1436

8863

1.68

68.65

7.9

8.3

122.9

122.1

g/l

0.69

1407

8521

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1259

7522

1.73

67.84

3.0

2.1

5.7

7.4

ug/l

1.51

1072

6572

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3146

23162

1.44

67.69

1.4

1.3

35.7

29.3

iu/ml

0.22

823

7026

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

12883

118712

1.42

65.83

3.9

3.4

1.3

1.2

mmol/l

14.68

11977

111471

(3023323) Follitropin [Units/volume] in Serum or Plasma

1525

9659

1.64

65.79

1.5

1.3

20.5

22.9

iu/l

2.36

1245

8309

(3003327) Ova and parasites identified in Stool by Light microscopy

946

5249

1.85

65.42

1.8

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2910

21246

1.45

65.16

1.9

1.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1056

6088

1.78

64.35

1.1

18.2

6.4

u/ml

0.30

(3029937) Albumin [Presence] in Urine by Test strip

4415

34774

1.37

63.43

4.5

3.6

0.0

estimate

0.87

1497

12686

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

547

2527

2.20

63.24

2.3

1.8

183.0

180.7

pmol/l

0.17

517

2407

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

755

3967

1.95

61.65

2.1

1.6

43.3

41.8

nmol/l

0.73

748

3875

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1298

8036

1.67

61.03

2.0

1.8

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1754

11682

1.56

61.01

21.2

19.3

1.2

inr

0.64

217

1861

(3024928) Oxygen saturation in Venous blood

477

2116

2.29

60.82

4.4

3.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1148

6915

1.71

59.81

8.1

7.7

25.0

24.7

mmol/l

2.47

1134

6874

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

660

3346

2.01

59.71

1.5

1.4

417.5

478.9

mg/l

3.25

633

3189

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

600

2942

2.08

59.48

1.4

3.7

3.6

mmol/l

0.68

561

2761

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1389

8819

1.63

59.05

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

5193

42308

1.33

58.68

2.4

2.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

600

2957

2.07

58.67

1.5

1306.9

2421.6

e6/l

0.30

492

2394

(3015235) Bicarbonate [Moles/volume] in Capillary blood

535

2525

2.16

58.60

3.5

3.1

24.4

24.3

mmol/l

0.18

472

2222

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

657

3350

2.00

58.48

2.2

2.4

529.8

506.4

ug/l

0.06

589

3073

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

599

2955

2.07

58.41

1.5

13.7

23.0

e6/l

0.73

460

2272

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2940

21952

1.41

57.25

1.3

8.2

10.1

u/ml

0.79

1066

9026

(3014765) Yersinia sp identified in Stool by Organism specific culture

730

3891

1.92

57.07

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

652

3349

1.99

56.82

1.7

1.5

0.3

0.5

nmol/l

1.70

532

2733

(3013512) EKG study

3744

29145

1.37

56.70

4.1

3.3

—

(3008295) Osmolality of Serum or Plasma

291

1060

2.78

56.32

2.4

1.5

282.1

282.0

mosm/kgh2o

0.04

223

830

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

722

3854

1.91

56.18

1.2

1.1

—

(3022313) Gas panel - Capillary blood

862

4868

1.81

56.13

4.8

4.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

729

3906

1.91

56.08

1.2

—

(3019060) Gas panel - Arterial blood

1002

5972

1.72

54.11

4.9

4.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1037

6261

1.70

53.40

1.5

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1336

8621

1.60

52.89

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

4873

39833

1.32

52.29

2.4

2.2

—

(3006653) Thiamine [Moles/volume] in Blood

191

576

3.34

51.40

1.3

1.4

143.0

134.3

nmol/l

1.30

191

576

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1721

11824

1.51

51.34

1.3

1.2

106.9

147.2

iu/ml

4.75

548

4554

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

471

2236

2.14

50.82

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

856

4967

1.76

50.77

9.0

9.9

24.4

24.2

mmol/l

1.37

782

4674

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

471

2237

2.14

50.76

1.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

735

4076

1.84

50.72

4.4

4.0

52.4

49.3

2.50

729

4027

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2634

19695

1.40

50.09

2.5

2.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1390

9173

1.56

49.84

2.3

20.7

21.3

au/ml

0.06

667

(40760892) CBC W Ordered Manual Differential panel - Blood

3935

31410

1.33

49.29

4.6

4.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

777

4427

1.79

49.03

4.1

3.6

25.1

mmol/l

0.05

756

4275

(3023520) Reticulocytes [#/volume] in Blood

1221

7850

1.60

48.96

2.9

2.7

70.8

70.1

e9/l

0.27

853

5817

(3007461) Platelets [#/volume] in Blood

15545

150613

1.89

48.29

26.1

16.8

259.4

258.9

e9/l

0.50

15292

147210

(3025941) Bacteria identified in Stool by Culture

1263

8231

1.58

47.76

1.3

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

542

2780

1.98

47.40

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

766

4401

1.78

46.96

5.0

4.1

24.6

mmol/l

0.12

733

4120

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1819

12853

1.47

46.94

7.7

5.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

954

5827

1.68

46.90

7.5

6.8

24.7

24.3

mmol/l

2.07

917

5406

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1286

8456

1.56

46.74

1.3

40.6

45.0

au/ml

0.21

335

(3035941) MCH [Entitic mass]

15548

150751

1.87

46.71

25.9

16.7

30.2

30.1

6.31

15420

149050

(1616796) Gas panel - Central venous blood

485

2406

2.05

46.57

3.6

3.4

—

(40761535) Cells panel - Urine sediment

1333

8845

1.55

46.52

3.9

3.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

962

5904

1.67

46.42

9.4

9.6

93.2

94.2

3.22

957

5883

(3026361) Erythrocytes [#/volume] in Blood

15549

150784

1.87

46.38

26.1

16.8

4.5

e12/l

16.62

15264

147094

(3024731) MCV [Entitic volume]

15546

150760

1.86

46.16

26.0

16.7

90.4

90.1

14.78

15416

149057

(3010813) Leukocytes [#/volume] in Blood

15549

150831

1.86

45.64

26.2

16.8

6.8

e9/l

0.50

15271

147094

(3028626) Oxygen [Partial pressure] in Capillary blood

553

2895

1.94

45.56

4.8

4.2

8.9

kpa

0.06

520

2706

(3000963) Hemoglobin [Mass/volume] in Blood

15548

150849

1.85

45.16

26.2

16.9

134.6

135.5

g/l

13.20

15419

149151

(3005719) IgG [Mass/volume] in Serum or Plasma

1439

9776

1.52

44.99

2.6

10.2

10.5

g/l

3.19

1297

8989

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5952

50748

1.27

44.15

4.2

3.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2126

15631

1.41

44.03

2.2

1.8

—

(3018405) Lactate [Moles/volume] in Arterial blood

596

3237

1.87

43.91

4.3

3.9

1.4

mmol/l

0.51

591

3179

(3020961) Endomysium IgA Ab [Titer] in Serum

1196

7892

1.56

42.66

1.2

1.1

58.1

212.3

titre

4.99

217

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

510

2657

1.95

42.63

1.8

1.6

—

(3022145) Colonoscopy Study observation

1812

13016

1.44

42.61

1.3

1.4

—

(40768804) Tissue Pathology biopsy report

5941

50827

1.27

42.28

2.0

—

(3003181) Sodium [Moles/volume] in Urine

340

1532

2.24

41.83

1.6

1.5

60.8

65.6

mmol/l

1.07

251

1222

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1691

12050

1.45

41.44

2.7

2.3

5733.8

6611.5

u/l

0.52

592

4869

(3015171) Extractable nuclear Ab [Units/volume] in Serum

888

5501

1.65

41.24

1.3

0.8

1.0

u/ml

0.17

455

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

638

3620

1.79

40.77

1.6

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3631

29295

1.31

40.77

2.6

2.4

2550.3

3311.7

umol/l

0.84

3157

25959

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1272

8598

1.52

40.57

4.2

3.6

1.2

mmol/l

1.41

1108

7564

(3019225) pH of Specimen

1439

10010

1.48

39.88

4.7

3.8

—

(3020891) Body temperature

644

3735

1.75

38.17

5.7

4.7

—

(3010421) pH of Blood

519

2827

1.86

37.89

4.3

3.9

7.4

0.60

439

2398

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4432

36970

1.27

37.85

1.9

1.7

—

(3023410) Appearance of Cerebral spinal fluid

305

1385

2.22

36.87

1.8

1.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1123

7541

1.52

36.83

1.8

1.3

g/l

0.22

1023

6984

(3009542) Hematocrit [Volume Fraction] of Blood

13523

128336

1.33

36.70

18.8

12.1

40.0

0.85

10497

101981

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

297

1338

2.24

36.60

2.3

2.4

21.2

21.4

nmol/l

0.13

281

1285

(3043409) Potassium [Moles/volume] in Arterial blood

503

2753

1.85

36.17

4.7

4.1

3.8

3.9

mmol/l

2.74

460

2580

(3020630) Protein [Mass/volume] in Serum or Plasma

1115

7510

1.52

36.04

2.1

2.4

66.1

66.8

g/l

2.51

1012

6923

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3666

30074

1.28

35.38

2.4

2.1

—

(3012501) Base excess in Blood by calculation

453

2435

1.88

34.49

4.4

3.9

2.3

mmol/l

0.14

301

1550

(21494755) Public health laboratory ask at order entry panel

1291

18043

0.69

34.48

1.3

—

(3013290) Carbon dioxide [Partial pressure] in Blood

453

2436

1.88

34.44

4.4

3.9

5.1

5.0

kpa

1.49

439

2397

(3027315) Oxygen [Partial pressure] in Blood

455

2453

1.88

34.32

4.4

3.9

9.1

8.9

kpa

2.08

441

2413

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

717

4407

1.65

34.28

2.0

1.8

1.4

g/l

0.12

617

3811

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

502

2820

1.80

33.19

1.3

—

(3021901) Oxygen saturation in Capillary blood

359

1809

2.01

33.08

3.0

2.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1495

10850

1.42

32.74

3.9

3.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1258

8864

1.45

32.38

2.9

2.4

71.7

73.2

ml/min/173m2

0.53

510

3344

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7010

62271

1.22

32.31

4.2

3.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

870

5683

1.56

32.28

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

895

5885

1.55

32.24

2.0

2.1

—

(3003338) MCHC [Mass/volume]

12671

119773

1.27

31.61

22.5

14.2

332.9

333.0

g/l

1.40

12583

118861

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

793

5129

1.57

30.72

1.6

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

333

1679

2.00

30.66

1.5

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

433

2384

1.84

30.59

1.1

—

(3036180) Methadone [Presence] in Urine

11.05

30.17

1.8

2.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1774

13431

1.36

29.95

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

797

5195

1.56

29.83

2.4

2.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

1341

9738

1.41

29.14

1.3

257.1

218.8

u/ml

0.21

1241

8977

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

797

5245

1.55

28.58

9.3

10.0

—

(3016018) Differential panel - Cerebral spinal fluid

296

1484

2.01

27.74

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1557

11701

1.36

27.44

3.7

4.2

227.4

235.1

u/l

2.02

1458

11117

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

655

4162

1.60

27.36

1.9

1.8

0.2

g/l

0.45

626

3974

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

705

4558

1.57

27.35

1.1

6.0

5.0

u/ml

0.19

103

664

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

137

494

2.79

27.27

1.0

252.3

322.0

ng/l

3.02

354

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1041

7315

1.45

27.07

2.7

2.8

162.7

163.2

ng/l

0.01

906

6558

(3036489) Thrombin time

766

5065

1.54

26.87

2.5

2.3

21.0

21.2

0.55

652

4297

(3013005) Retinol [Moles/volume] in Serum or Plasma

169

685

2.48

26.62

1.8

2.1

1.9

umol/l

0.19

154

644

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

408

2305

1.79

26.52

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1115

15304

0.71

26.33

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

666

4289

1.58

26.28

1.9

1.8

1.2

g/l

0.40

637

4104

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

134

500

2.69

25.02

1.0

33.5

43.5

ng/l

2.77

352

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

133

497

2.69

24.77

1.0

867.5

734.7

ng/l

2.19

347

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

8.06

24.69

1.5

1.3

352.4

633.0

nmol/l

1.72

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

494

3016

1.66

24.28

1.5

1.3

17.4

21.6

u/l

2.76

418

2508

(4010399)

1112

8063

1.41

24.25

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

434

2562

1.71

24.21

1.9

2.0

0.0

g/l

0.24

390

2358

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

511

3156

1.64

24.00

1.9

2.1

3.0

g/l

0.55

396

2481

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

534

3339

1.62

23.87

1.9

2.0

7.2

7.3

g/l

0.40

395

2529

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

533

3336

1.62

23.73

1.9

2.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

531

3334

1.61

23.34

1.9

2.0

3.7

3.8

g/l

1.05

382

2400

(3016244) Insulin [Units/volume] in Serum or Plasma

244

1221

2.01

23.07

3.3

27.3

27.6

mu/l

0.04

224

1156

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

205

967

2.13

22.71

1.7

1.5

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

724

4909

1.50

22.55

1.5

1.6

7.3

11.7

u/ml

0.99

159

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

463

2837

1.65

22.46

2.1

0.6

0.7

g/l

0.52

398

2484

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

498

3108

1.62

22.45

1.9

2.1

9.7

10.3

g/l

2.99

412

2638

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

623

4096

1.54

22.44

2.6

2.8

173.7

174.9

0.14

581

3881

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

547

3493

1.58

22.41

2.2

2.0

2.1

ug/l

0.14

490

3083

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

599

3906

1.55

22.39

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

11403

107765

1.20

22.37

4.0

3.6

—

(40767503) Oxygen content in Capillary blood by calculation

381

2221

1.73

22.28

3.0

2.4

17.1

16.8

0.61

207

1114

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

534

3407

1.59

21.96

6.1

5.0

1.4

mg/l

1.36

495

3208

(3047181) Lactate [Moles/volume] in Blood

518

3288

1.59

21.78

5.4

5.6

1.4

1.3

mmol/l

1.73

466

2902

(3020717) Zinc [Moles/volume] in Serum or Plasma

168

748

2.26

21.51

1.6

21.8

24.7

umol/l

0.65

153

717

(3004716) Salmonella sp identified in Stool by Organism specific culture

1210

9103

1.35

20.99

1.4

—

(3049717) Cytology report of Urine Cyto stain

475

2980

1.61

20.98

2.3

2.5

—

(3028271) Lactate [Moles/volume] in Capillary blood

300

1663

1.82

20.86

2.7

1.8

1.7

mmol/l

0.19

293

1626

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

380

2255

1.70

20.85

3.8

2.4

0.9

0.8

nmol/l

1.17

319

1917

(3024891) Influenza virus A+B Ag [Presence] in Specimen

583

3842

1.54

20.79

1.2

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

120

4.34

20.73

1.1

1.2

48.4

44.9

mg/l

0.25

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

159

3.84

20.67

5.2

8.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

912

6567

1.41

20.67

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

421

2579

1.65

20.48

1.9

2.0

38.7

38.2

g/l

1.09

361

2255

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

391

2350

1.68

20.47

1.9

2.0

0.0

g/l

1.01

349

2154

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

578

3826

1.53

20.21

1.2

1.3

44.3

33.2

u/ml

0.29

251

(3051611) Lipemic interference index of Serum or Plasma

215

1080

2.00

20.17

3.3

3.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

815

5783

1.43

20.06

3.2

2.5

0.3

e6/l

0.56

785

5591

(3017181) Myelocytes/100 leukocytes in Blood

1314

10075

1.33

20.04

4.2

0.9

0.8

0.09

367

2546

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

215

3.36

19.96

1.0

1.1

81.7

74.1

ug/l

0.80

183

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

384

2320

1.67

19.72

2.0

0.0

g/l

0.00

349

2150

(3007566) Smooth muscle Ab [Titer] in Serum

551

3645

1.53

19.33

1.2

1.3

63.1

120.8

titre

2.74

357

(3021440) Promyelocytes/100 leukocytes in Blood

1256

9627

1.33

19.19

4.2

4.3

0.1

0.46

344

2370

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

505

3284

1.55

19.15

1.6

1.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

292

1652

1.78

19.02

1.3

0.6

1.5

nmol/l

0.70

279

1597

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

136

584

2.34

19.01

1.7

2.2

29.0

27.7

umol/l

0.86

127

567

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

501

3260

1.55

18.95

1.5

1.4

16.4

21.2

u/ml

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

736

5187

1.44

18.81

2.0

1.9

39.7

39.3

u/l

0.23

672

4735

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

586

3955

1.50

18.70

1.6

214.2

290.3

titre

0.29

166

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

152

690

2.21

18.64

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

537

3561

1.52

18.64

1.2

1.3

1100.0

1006.7

titre

—

108

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

155

710

2.19

18.59

1.1

0.3

7.7

nmol/l

2.27

144

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

465

2993

1.57

18.47

1.2

1.3

40.1

37.9

u/ml

0.10

287

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

6.21

18.41

2.2

2.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

646

4460

1.47

18.41

3.4

2.7

95.2

93.5

1.20

585

4132

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

290

1656

1.76

18.31

1.3

0.2

nmol/l

0.06

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

527

3494

1.52

18.31

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

502

3294

1.54

18.30

1.4

1.3

244.3

251.5

u/ml

0.26

340

2075

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

455

2925

1.57

18.17

4.6

3.9

0.4

0.3

u/ml

0.30

234

1641

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

471

3052

1.56

18.17

1.5

100.3

109.1

u/ml

1.36

123

649

(3025159) Blasts/100 leukocytes in Blood

1196

9175

1.33

18.14

4.3

0.0

0.2

1.28

288

2015

(3002179) Metamyelocytes/100 leukocytes in Blood

1205

9257

1.33

18.10

3.8

4.0

0.6

0.04

267

1874

(3040151) Glucose [Moles/volume] in Capillary blood

231

1240

1.87

17.88

34.6

4.7

7.3

7.2

mmol/l

0.21

190

1013

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

170

822

2.08

17.77

1.4

74.0

72.7

0.68

158

787

(3051651) Icteric interference index of Serum or Plasma

150

693

2.17

17.64

3.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

477

3129

1.54

17.43

1.4

7.2

11.9

iu/ml

—

(3044242) Glucose [Moles/volume] in Arterial blood

108

436

2.49

17.34

1.9

2.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

394

2479

1.60

17.27

2.3

2.1

133.5

131.4

g/l

0.99

301

1839

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

405

2566

1.59

17.24

5.1

5.8

1343.0

1802.6

iu/ml

0.19

328

(3026389) Candida sp identified in Specimen by Organism specific culture

342

2088

1.65

16.93

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

151

713

2.13

16.83

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

260

1477

1.77

16.76

1.2

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

568

3899

1.47

16.69

4.9

5.0

1.9

1.7

1.87

547

3638

(3016038) Potassium [Moles/volume] in Urine

135

612

2.21

16.67

1.5

1.4

30.9

35.7

mmol/l

1.41

113

535

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

164

803

2.05

16.61

1.4

576.4

480.9

mu/l

0.76

152

768

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

533

7699

0.68

16.54

1.7

1.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

412

2647

1.57

16.54

1.4

—

(3007463) Buprenorphine [Presence] in Urine

4.64

16.51

7.2

5.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

512

3455

1.50

16.39

1.2

1.3

2.0

7.6

u/ml

2.47

356

(3045716) Anion gap in Serum or Plasma

105

430

2.45

16.38

2.0

2.3

9.3

9.2

mmol/l

0.09

333

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

615

4303

1.45

16.37

1.8

2.0

—

(40768443) Skin Pathology biopsy report

693

4957

1.41

16.33

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

100

401

2.50

16.31

1.4

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

264

1519

1.75

16.30

1.1

—

52.5

—

(3017509) Phencyclidine [Presence] in Urine

249

2.94

16.28

3.4

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

4215

37399

1.17

16.20

3.6

2.9

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

149

714

2.10

16.00

1.9

1.7

1898035.6

1514994.7

iu/ml

0.15

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

516

3511

1.48

15.87

1.2

1.3

6.6

9.2

u/ml

0.64

559

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

266

1552

1.72

15.65

1.1

—

23.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

447

2962

1.52

15.63

2.4

2.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

792

10595

0.73

15.61

1.4

1.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

120

533

2.26

15.60

2.1

2.7

1.1

1.2

ug/l

0.47

114

504

(3007930) Methemoglobin/Hemoglobin.total in Blood

555

3849

1.46

15.50

5.1

0.9

0.80

535

3597

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

303

1842

1.66

15.30

1.7

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

353

2231

1.59

15.24

1.5

1.6

0.7

g/l

0.19

260

1723

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

592

4174

1.43

15.14

3.7

2.9

3.6

3.5

g/l

0.35

547

3968

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

305

2.66

15.05

2.4

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

305

2.66

15.05

2.4

2.8

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

317

1967

1.62

14.78

3.2

3.3

660.0

1542.4

u/ml

0.94

105

(3025130) Human papilloma virus identified in Specimen

405

2661

1.53

14.75

1.8

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

397

2.42

14.71

2.4

2.8

26.8

28.4

umol/l

0.51

294

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

228

1298

1.77

14.66

1.4

1.3

5.2

5.9

umol/l

2.23

206

1211

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2961

25701

1.19

14.64

4.5

4.4

2.1

2.8

ug/l

2.31

2655

23239

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

385

2510

1.55

14.54

1.1

3.5

2.8

u/ml

0.56

177

1283

(4062490)

246

1435

1.72

14.52

1.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

346

2.52

14.49

1.8

1.6

0.2

nmol/l

2.02

258

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

110

487

2.27

14.44

1.4

1.5

13.6

14.5

pmol/l

0.93

415

(4034850)

537

3756

1.44

14.36

10.3

8.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

307

2.61

14.34

1.4

1.3

103.9

114.8

nmol/l

0.28

238

(3019977) pH of Arterial blood

115

522

2.21

14.23

2.3

2.8

7.4

0.81

162

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

214

1208

1.78

14.18

1.3

1.5

—

(3036603) Volume of Urine

140

689

2.04

14.07

1.5

1.7

2136.5

2013.7

0.25

143

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

439

2969

1.49

13.96

1.4

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

163

849

1.93

13.94

3.6

4.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

463

3172

1.47

13.81

2.0

1.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

191

1059

1.81

13.46

1.2

1.3

1.8

1.9

mmol/l

0.50

179

989

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

218

1258

1.74

13.41

7.1

6.8

11.1

mg/l

0.01

199

1170

(3027135) IgG subclass 1 [Mass/volume] in Serum

241

1432

1.69

13.34

1.3

1.4

6.3

6.7

g/l

0.66

165

1015

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

410

2.32

13.28

1.1

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

179

980

1.83

13.16

1.4

10.6

11.3

umol/l

0.67

168

936

(3017950) Salicylates [Moles/volume] in Serum or Plasma

7.31

13.09

4.1

2.9

1566.3

2077.3

umol/l

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

240

1432

1.68

13.09

1.3

1.4

2.9

3.0

g/l

0.32

166

1014

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

456

6477

0.69

12.94

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

203

1161

1.76

12.91

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

609

8238

0.73

12.89

1.5

1.6

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

239

1432

1.68

12.84

1.3

1.4

0.4

g/l

0.32

165

1016

(3011985) Renin [Units/volume] in Plasma

261

1603

1.64

12.75

1.8

1.7

62.7

67.5

mu/l

0.15

232

1453

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

381

2554

1.50

12.69

1.7

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

236

1415

1.68

12.66

1.0

1.1

—

(3008898) HLA-B27 [Presence]

801

6122

1.32

12.47

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

362

2428

1.50

12.05

2.3

1.8

3.6

7.0

titre

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

106

503

2.11

11.82

5.6

4.9

81.2

3006.2

mg/l

2.29

373

(3045414) Leukocytes [Presence] in Urine

746

5690

1.33

11.80

1.9

1.8

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

367

2484

1.49

11.70

2.8

3.1

43.5

73.8

mg/l

0.70

290

1991

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

367

2484

1.49

11.70

1.8

1.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

405

2796

1.46

11.68

1.2

1.3

13.3

3.2

u/ml

0.59

206

(3019420) Tryptase [Mass/volume] in Serum or Plasma

152

823

1.85

11.64

1.4

5.6

6.7

ug/l

1.26

141

738

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3865

34770

1.15

11.60

1.9

1.7

—

(3000492) Spirometry study

1553

12966

1.22

11.53

1.5

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

559

4096

1.38

11.52

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

193

1126

1.72

11.50

1.2

67.0

67.7

u/l

0.03

138

759

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

463

3287

1.42

11.49

1.9

2.0

11.1

10.6

mg/l

0.71

425

3088

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

261

1647

1.59

11.46

1.2

1.3

—

(1761868) Lipid panel - Serum or Plasma

4556

49778

0.88

11.34

2.7

2.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

365

2485

1.48

11.32

2.8

3.1

32.3

48.0

mg/l

1.73

287

1999

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

357

2420

1.48

11.31

2.7

3.0

1.3

2.2

ratio

1.10

216

(3011648) Oxygen content in Venous blood

157

867

1.82

11.30

4.5

3.3

11.0

11.2

0.27

157

867

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

348

2348

1.49

11.29

1.4

1.2

4.0

4.2

u/ml

0.08

160

1031

(3017315) Amylase [Enzymatic activity/volume] in Urine

124

635

1.96

11.25

1.4

1.3

214.5

328.4

u/l

1.50

117

583

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

602

4485

1.35

11.17

1.5

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

275

2.48

11.05

1.4

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

127

661

1.93

11.00

1.4

1.7

3.0

14.8

nmol/l

0.75

103

550

(3012920) Ethanol [Mass/volume] in Serum or Plasma

5.72

10.98

2.3

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1406

16801

0.82

10.97

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

128

3.21

10.75

13.0

9.7

4.9

5.8

mmol/l

1.56

128

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

103

506

2.04

10.53

1.3

1.2

109.1

108.7

0.04

455

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

293

1937

1.52

10.51

1.4

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

427

2.14

10.50

2.4

2.8

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

422

2.14

10.40

1.1

1.2

31.9

19.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

6.00

10.37

1.2

—

mmol/l

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

108

543

1.99

10.36

1.2

1.1

3.4

3.9

iu/ml

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

137

746

1.84

10.36

1.3

1.5

7.7

5.7

u/l

0.91

115

636

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

104

517

2.02

10.30

1.4

1.3

139.2

71.8

titre

0.30

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

176

1035

1.71

10.24

1.3

1.2

—

(3037121) Protein [Mass/volume] in Urine

535

3978

1.36

10.10

3.7

3.3

0.3

g/l

0.19

249

1825

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

189

1138

1.67

10.08

1.1

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

120

633

1.90

10.03

1.2

22.4

19.4

u/l

0.23

106

545

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

176

1042

1.70

10.01

1.3

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

114

595

1.92

9.84

41.6

37.2

7.6

7.4

ug/l

0.49

109

553

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

187

1135

1.65

9.69

1.1

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

244

2.46

9.69

6.4

6.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

121

3.14

9.68

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

498

3687

1.36

9.68

1.8

2.0

2.9

6.4

iu/l

1.01

154

1485

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

187

1136

1.65

9.66

1.1

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

196

1208

1.63

9.57

1.6

1.7

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

185

1125

1.65

9.53

1.1

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

167

991

1.69

9.44

1.3

1.4

1.5

nmol/l

0.18

153

892

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

309

2114

1.47

9.43

3.4

3.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

105

542

1.94

9.39

1.4

1.3

748.9

411.5

titre

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

268

1783

1.51

9.39

1.9

1.8

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

184

1123

1.64

9.35

1.1

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

223

1428

1.57

9.30

1.8

1.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

184

1127

1.64

9.23

1.1

1.2

—

(4027681)

175

1061

1.66

9.14

1.3

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

252

1665

1.52

9.13

3.0

3.1

1.5

1.4

0.09

186

1291

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

201

1263

1.60

9.09

1.1

—

(44790047)

202

1272

1.59

9.06

1.5

1.6

—

(44790049)

202

1272

1.59

9.06

1.5

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

612

4717

1.31

9.06

2.2

2.0

—

(44790048)

202

1273

1.59

9.03

1.5

1.6

—

(44806118)

202

1273

1.59

9.03

1.5

1.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

124

685

1.82

9.02

1.4

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

211

2.52

8.98

1.1

0.6

1.0

umol/24h

0.62

110

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

162

968

1.68

8.95

1.3

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

188

2.61

8.95

1.5

33.9

68.0

ng/l

1.16

113

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

170

1031

1.65

8.88

1.4

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

263

1766

1.50

8.84

1.2

1.3

64.7

52.1

u/ml

0.19

116

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

209

1336

1.57

8.81

1.2

32.4

40.1

mg/l

2.10

171

1108

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2310

20394

1.15

8.80

4.0

3.8

21.7

21.8

0.08

924

8975

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

314

2188

1.44

8.74

1.2

1.1

87.7

4817.8

iu/ml

0.64

565

(43055514) Macroprolactin [Presence] in Serum or Plasma

117

643

1.82

8.67

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

242

1605

1.51

8.64

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

281

1923

1.47

8.61

3.3

2.9

1.6

1.5

mmol/l

0.75

276

1876

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

119

659

1.81

8.61

1.2

80.6

84.0

u/l

0.16

105

577

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

268

1818

1.48

8.58

1.6

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

228

1498

1.53

8.52

1.4

400.4

364.8

pmol/l

0.36

186

1165

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

205

2.49

8.49

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

218

1420

1.54

8.47

1.2

1.1

—

56.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

922

11203

0.81

8.45

1.4

—

(3022621) pH of Urine by Test strip

983

8090

1.23

8.41

3.2

2.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

341

2434

1.41

8.33

1.3

1.2

3.6

3.7

u/ml

0.05

112

843

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

559

4308

1.31

8.31

2.1

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

229

1515

1.52

8.30

1.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

124

704

1.77

8.27

1.2

1.3

45.1

71.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

291

2026

1.44

8.17

1.9

1.6

1800.0

2185.5

titre

0.20

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

201

1298

1.55

8.14

1.1

219.8

232.2

mg/l

0.49

176

1133

(3000012) Reticulocyte production index

506

1.90

8.14

1.3

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

108

592

1.83

8.10

1.3

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

338

2.10

8.00

1.3

1.4

16.3

16.9

umol/l

0.56

298

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

111

618

1.80

7.93

2.9

2.6

55.0

52.3

umol/l

0.32

538

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

165

1025

1.61

7.89

2.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

317

2260

1.41

7.83

1.1

118.8

116.8

0.57

282

2050

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

350

2543

1.38

7.74

1.1

21.8

9.9

au/ml

0.90

177

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

296

2090

1.42

7.73

1.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

167

1047

1.60

7.71

1.1

297.3

288.6

mg/l

0.60

149

950

(3023420) DNA double strand Ab [Units/volume] in Serum

227

1524

1.50

7.70

1.7

1.6

33.0

32.8

iu/ml

0.01

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

109

613

1.78

7.55

1.5

35.3

20.7

u/ml

1.11

125

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

319

2292

1.40

7.55

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

327

2360

1.39

7.54

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

534

1.84

7.53

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

259

1796

1.45

7.47

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

502

1.86

7.37

2.8

2.5

196.0

216.1

e6/l

0.28

284

(3017569) Oxygen content in Arterial blood

397

1.97

7.37

2.0

2.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

150

927

1.62

7.36

1.8

2.6

96.0

97.4

0.25

137

856

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

143

2.66

7.27

1.7

1.6

1.3

1.9

mg/l

0.57

100

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

143

2.66

7.27

1.7

1.6

2.5

1.9

mg/l

0.24

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

143

2.66

7.27

1.7

1.6

1.7

3.0

mg/l

1.09

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

143

2.66

7.27

1.7

1.6

1.5

2.3

mg/l

0.41

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

143

2.66

7.27

1.7

1.6

0.9

2.7

mg/l

2.47

101

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

143

2.66

7.27

1.7

1.6

0.5

1.1

mg/l

1.22

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

143

2.66

7.27

1.7

1.6

3.8

4.0

mg/l

0.04

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

143

2.66

7.27

1.7

1.6

1.2

2.8

mg/l

2.01

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

143

2.66

7.27

1.7

1.6

0.6

1.3

mg/l

1.01

(40760888) Immunoglobulin light chains.free panel - Serum

268

1882

1.43

7.24

2.9

3.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

182

1183

1.54

7.22

1.9

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

520

1.83

7.21

1.8

2.6

24.7

51.1

umol/l

1.34

(3006270) Folate [Moles/volume] in Blood

147

914

1.61

7.06

1.1

394.4

388.7

nmol/l

0.13

140

809

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

169

2.49

7.04

2.9

2.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

439

1.89

7.03

2.3

2.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

418

1.92

7.02

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

135

823

1.64

7.02

1.9

0.9

1.2

g/24h

0.37

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

218

1482

1.48

7.00

1.5

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

151

948

1.60

6.98

3.1

3.0

83.4

65.7

mg/l

0.28

104

706

(3047007) Chlamydophila sp Ab [Presence] in Serum

320

2334

1.38

6.96

1.3

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

180

1178

1.53

6.94

2.3

3.0

3.8

9.0

nmol/l

0.57

169

1142

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

325

2.03

6.86

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

163

1048

1.56

6.81

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

217

1484

1.47

6.78

1.5

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

354

1.98

6.77

1.8

1.5

—

(40761536) Microorganisms panel - Urine sediment

1375

11906

1.17

6.75

4.5

3.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

148

933

1.59

6.74

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

149

2.55

6.73

1.7

1.6

1.3

2.1

mg/l

0.59

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

221

1519

1.46

6.73

1.5

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

150

949

1.58

6.73

1.4

1.3

63.9

90.0

pmol/l

0.36

294

(3021367) Citalopram [Moles/volume] in Serum or Plasma

5.00

6.69

1.4

189.3

97.7

nmol/l

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

215

1472

1.47

6.68

1.5

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

330

2.00

6.60

1.0

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

215

1476

1.46

6.60

1.5

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

148

939

1.58

6.57

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

215

1478

1.46

6.55

1.5

1.4

—

(3002256) Pathology report gross observation

1762

15579

1.15

6.51

1.2

—

(3037756) Immunofixation for Serum or Plasma

232

1622

1.44

6.47

1.5

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

395

1.90

6.47

2.6

2.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

104

606

1.72

6.44

1.7

1.9

1.3

nmol/l

0.03

475

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

306

2.03

6.44

1.0

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

562

1.75

6.42

1.2

114.1

109.7

0.45

503

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

320

2.00

6.41

1.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

221

1535

1.44

6.39

1.6

1.4

—

(3017732) Neutrophils [#/volume] in Blood

1078

9192

1.18

6.39

2.8

2.5

4.0

4.2

e9/l

1.45

841

7531

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

128

792

1.62

6.32

1.3

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

171

1131

1.52

6.32

3.4

3.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

173

1148

1.51

6.30

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

567

1.73

6.24

1.3

1.2

0.3

g/l

0.43

457

(3038515) Glucose [Moles/volume] in Venous blood

250

1789

1.40

6.15

3.4

3.0

7.0

7.4

mmol/l

1.24

245

1751

(3006922) Hepatitis E virus Ab [Presence] in Serum

156

1019

1.54

6.13

1.1

—

(3021788) Differential panel - Synovial fluid

256

1841

1.40

6.12

1.6

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

312

2319

1.35

6.08

2.4

2.5

99.9

113.3

ug/min

0.18

183

1482

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

162

1069

1.52

6.07

1.7

1.8

—

(4306422)

319

2381

1.35

6.05

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

233

2.15

6.05

1.2

—

(3012898) Urea [Moles/volume] in Urine

116

2.67

6.05

1.7

194.0

165.7

mmol/l

0.60

108

(3039000) Anion gap in Blood

299

2212

1.36

6.01

7.1

6.8

11.6

11.3

mmol/l

0.62

281

1978

(3018572) Chloride [Moles/volume] in Blood

299

2213

1.36

6.00

7.1

6.8

104.6

105.4

mmol/l

1.84

281

1979

(3014271) Vancomycin [Susceptibility]

385

1.87

5.96

3.3

2.8

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

357

1.91

5.95

1.1

1.2

102.6

105.4

0.28

338

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

182

1238

1.47

5.90

1.3

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

187

1279

1.47

5.90

1.7

1.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

228

1619

1.41

5.88

1.1

94.2

94.1

0.01

206

1520

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

145

941

1.54

5.88

3.4

2.7

—

(3045424) Erythrocytes [Presence] in Urine

286

2111

1.36

5.85

1.5

1.4

—

(3042733) HLA Ab [Presence] in Serum

431

1.81

5.83

5.5

4.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

868

7323

1.19

5.83

1.4

1.3

212.2

230.4

miu/ml

0.74

371

3636

(3000093) Morphology [Interpretation] in Blood Narrative

151

993

1.52

5.78

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1483

13066

1.15

5.77

4.2

3.7

32.0

32.2

0.26

1112

9439

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3243

29928

1.10

5.73

1.6

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

316

2377

1.34

5.72

1.7

1.6

12752.3

12739.6

e6/l

0.00

239

1726

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

479

1.76

5.67

1.3

1.2

—

(3042631) Mycobacterium sp identified in Specimen

172

1169

1.48

5.63

2.7

2.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

329

1.92

5.63

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

241

2.08

5.58

1.6

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

202

2.18

5.56

1.8

1.9

—

(3044941) Cell count panel - Synovial fluid

217

1545

1.41

5.54

1.5

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

153

1020

1.50

5.51

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

325

1.91

5.49

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

165

2.30

5.48

1.0

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

582

1.67

5.47

1.6

1.8

136.6

149.8

0.97

550

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

341

2613

1.31

5.44

1.5

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

174

1195

1.46

5.42

3.2

3.0

0.8

nmol/l

0.11

133

880

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

160

1081

1.48

5.41

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

211

2.13

5.40

1.7

1.6

0.4

ug/l

0.11

143

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

162

1099

1.48

5.37

2.3

2.2

10.5

13.0

2.60

105

580

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

124

796

1.56

5.32

1.6

1.8

122.6

129.7

0.69

113

751

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

198

1398

1.42

5.32

1.6

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

164

1119

1.47

5.29

2.3

2.2

75.9

73.5

1.34

159

1084

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

542

1.68

5.29

1.1

92.5

94.4

0.12

251

(3036071) Salmonella sp Ab [Titer] in Serum

490

1.72

5.27

1.1

—

(3011412) CD3 cells [#/volume] in Blood

193

1361

1.42

5.23

2.3

2.6

1.4

1.2

e9/l

1.20

129

803

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

345

1.86

5.22

1.2

1.1

77.1

72.2

0.21

(4268621)

228

1656

1.38

5.21

2.5

2.3

—

(3023419) Bacteria identified in Sputum by Culture

164

1124

1.46

5.18

2.4

2.7

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

346

1.85

5.18

1.2

1.1

89.8

82.4

0.38

(3017354) Segmented neutrophils/100 leukocytes in Blood

150

1012

1.49

5.13

2.6

3.2

56.7

57.2

0.09

643

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

393

1.78

5.03

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

404

1.76

4.89

1.3

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

419

1.74

4.88

1.3

1.2

—

(3012565) Volume of 24 hour Urine

555

1.64

4.87

1.9

2.2

2025.9

2015.3

0.02

511

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

259

1945

1.34

4.81

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

362

2845

1.28

4.81

2.2

2.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

557

1.64

4.80

1.1

91.7

94.1

0.23

251

(3006442) Creatine [Moles/volume] in Serum or Plasma

131

873

1.50

4.79

1.8

1.4

61.3

69.3

umol/l

0.79

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.06

4.77

1.7

1.3

16.2

22.9

nmol/l

0.46

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

285

1.90

4.74

1.2

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

152

1047

1.46

4.72

1.2

1.3

0.4

1.0

u/ml

1.25

414

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

150

1031

1.46

4.71

2.3

2.8

608.8

507.1

e6/l

0.80

118

853

(3001556) Androgen free Index in Serum or Plasma

265

1.93

4.69

1.5

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

118

773

1.53

4.68

2.0

1.6

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

158

2.22

4.66

1.2

—

(44813793)

170

1199

1.42

4.66

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

127

2.36

4.62

1.4

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

205

2.05

4.60

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

253

1.94

4.60

1.6

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

153

2.22

4.56

1.7

1.6

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.80

4.53

1.2

1.3

1.4

0.6

umol/24h

—

(3019832) Treponema pallidum Ab [Presence] in Serum

3018

28067

1.09

4.43

1.9

1.7

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

136

2.28

4.42

1.2

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

138

947

1.46

4.40

2.6

2.3

—

(3028433) Virus identified in Specimen by Culture

418

1.70

4.38

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

100

642

1.56

4.37

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

426

1.69

4.36

1.2

—

0.2

g/l

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

129

876

1.48

4.34

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

129

876

1.48

4.34

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

129

876

1.48

4.34

1.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

163

2.15

4.34

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

345

1.77

4.33

1.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

628

1.56

4.32

1.4

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

211

1.99

4.28

2.7

2.5

1.4

1.5

mmol/l

0.02

148

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

186

2524

0.73

4.27

1.6

7.3

7.5

mmol/l

0.50

112

1534

(3018133) Calcium [Moles/volume] in Urine

262

1.87

4.18

2.5

2.3

2.5

2.7

mmol/l

0.31

240

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.53

4.11

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

103

676

1.53

4.11

1.7

—

(4146454)

132

912

1.45

4.09

2.6

2.7

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

480

1.63

4.09

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

480

1.63

4.09

1.4

—

(3000330) Specific gravity of Urine by Test strip

638

5418

1.18

4.08

3.5

3.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

171

1240

1.38

4.05

1.6

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

128

882

1.45

4.03

1.1

1.0

u/l

0.22

377

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

153

1092

1.40

3.98

1.2

1.3

187.1

222.9

titre

0.17

212

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

102

676

1.51

3.91

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1628

14788

1.11

3.88

2.7

2.8

0.6

0.7

ug/l

2.67

1038

9081

(3035285) Chloride [Moles/volume] in Venous blood

146

1039

1.41

3.88

2.7

2.1

105.7

105.6

mmol/l

0.12

146

1028

(3041354) Potassium [Moles/volume] in Venous blood

146

1040

1.41

3.86

2.7

2.1

4.0

mmol/l

0.79

146

1029

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

113

768

1.47

3.84

2.0

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

171

1253

1.37

3.82

2.0

28.7

23.8

mg/l

0.41

337

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

142

1010

1.41

3.79

2.4

2.8

0.2

e9/l

0.14

115

854

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

101

673

1.50

3.79

1.7

1.6

6.0

4.7

u/l

0.38

326

(3010838) Calcium [Moles/time] in 24 hour Urine

522

1.57

3.78

1.8

1.7

5.9

6.3

mmol/24h

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

186

1387

1.34

3.73

2.7

4.6

66.3

80.9

u/ml

0.18

462

(4094501)

339

2735

1.24

3.71

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.56

3.70

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.50

3.69

1.1

10.1

11.4

u/l

0.11

(3043410) Blood group antigens tested for on Red Blood Cells

340

1.71

3.69

1.8

1.6

—

(40768446) Kidney Pathology biopsy report

520

1.56

3.62

2.2

1.6

—

(3025315) Body weight

2.47

3.61

4.6

3.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

118

820

1.44

3.60

1.5

20963.3

54573.4

e6/l

2.05

495

(3030313) Adrenal Ab [Titer] in Serum

197

1.93

3.60

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

314

2522

1.25

3.59

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

452

1.59

3.54

1.0

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

507

1.56

3.54

1.1

41.7

443.6

ng/l

—

118

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

170

1264

1.35

3.50

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

196

1491

1.32

3.46

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

222

1.85

3.43

2.6

2.7

58.4

24.7

mg/l

0.54

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

327

1.68

3.36

1.3

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

162

1205

1.35

3.34

2.5

2.4

45.2

43.8

0.17

171

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

507

1.54

3.33

2.1

1.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

476

1.56

3.31

2.0

36.9

152.2

ug/min

1.25

101

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.71

3.31

3.4

3.2

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.36

3.30

1.5

1.3

1.7

2.1

ml/s/173m2

0.20

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1962

18135

1.09

3.29

1.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

284

1.73

3.29

1.3

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.41

3.29

1.5

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

182

2374

0.76

3.28

1.5

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

2.58

3.20

7.8

10.9

100.4

322.9

e6/l

0.77

(3024471) HLA-A [Type]

442

1.56

3.16

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.73

3.14

1.4

2.8

—

(3011897) Casein IgE Ab [Units/volume] in Serum

388

1.60

3.13

1.1

1.3

54.0

3.9

u/ml

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

220

1726

1.28

3.12

1.1

1.5

g/l

0.98

197

1578

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

420

1.57

3.11

1.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

138

1014

1.36

3.11

2.8

2.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

237

1.77

3.11

1.6

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

126

914

1.38

3.08

1.5

4708.0

2568.1

e6/l

0.53

676

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

101

705

1.43

3.07

1.2

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

132

2.05

3.05

1.3

20.3

14.9

nmol/l

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.37

3.04

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

128

933

1.37

3.04

1.2

61.0

61.4

u/ml

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

128

938

1.37

2.96

1.2

43.6

45.7

u/ml

0.04

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

137

1016

1.35

2.94

1.1

6.7

7.7

iu/ml

0.20

271

(3010375) cycloSPORINE [Mass/volume] in Blood

588

1.46

2.93

23.4

26.9

111.0

121.0

ug/l

0.54

493

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

515

1.50

2.93

2.1

1.5

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

123

898

1.37

2.91

1.2

5.1

11.0

u/ml

—

(3024932) HLA-DR beta [Type]

436

1.54

2.89

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

246

1976

1.25

2.89

1.2

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

331

2746

1.21

2.86

1.3

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

354

4213

0.84

2.83

1.1

1.2

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

471

1.51

2.82

1.5

1.4

5.6

5.8

nmol/l

0.12

450

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

570

1.46

2.79

2.0

1.5

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.22

2.76

8.8

8.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.16

2.75

1.0

1.1

—

(3007147) Virus identified in Stool by Electron microscopy

8.33

2.75

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

111

2.07

2.71

2.0

2.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

348

1.58

2.70

2.4

2.2

129.5

109.6

ng/l

0.49

220

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

106

766

1.39

2.70

1.3

1.1

—

(3012441) Differential panel - Pleural fluid

109

792

1.38

2.69

1.6

1.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

113

827

1.37

2.67

1.2

3.1

18.4

u/ml

1.76

100

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

119

2.02

2.64

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

106

2.08

2.61

1.0

1.1

1.2

21.3

u/ml

0.47

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

309

2574

1.20

2.60

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

126

944

1.34

2.57

1.3

1.2

—

(3044927) Protein electrophoresis panel - Urine

107

782

1.37

2.56

1.1

—

(3022689) Creatine [Moles/volume] in Urine

306

1.60

2.56

1.6

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

105

766

1.37

2.55

1.2

1.3

6.0

6.2

mmol/l

0.21

713

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

128

1.95

2.53

1.1

1.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

134

1016

1.32

2.53

1.4

1.5

33.1

33.5

g/l

0.14

115

930

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

475

4114

1.16

2.52

1.4

1.3

4.0

3.6

ug/l

0.43

444

3836

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.03

2.52

1.4

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

289

2402

1.21

2.50

4.5

3.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

443

3820

1.16

2.50

1.9

2.3

6.0

umol/l

0.01

336

2806

(3020393) Adenovirus Ag [Presence] in Stool

181

1.77

2.42

1.5

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

138

1776

0.77

2.35

1.4

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

501

1.44

2.32

1.1

—

(3002619) Bacteria identified in Specimen by Culture

252

1.63

2.31

1.1

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

214

1.68

2.30

1.2

0.7

122.3

mg/l

2.09

157

(4015189)

214

1.68

2.30

2.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

133

1.88

2.30

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

112

1.96

2.29

1.0

1.1

1.5

1.8

umol/24h

0.97

112

(40768806) Pleura Pathology biopsy report

108

807

1.34

2.29

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

269

1.60

2.27

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

157

1237

1.27

2.26

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

106

1.98

2.24

1.0

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

156

1.79

2.24

2.4

3.1

15.6

6.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.15

2.23

1.9

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.15

2.23

1.9

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

259

2159

1.20

2.22

2.5

—

(3028717) Thiamine [Mass/volume] in Blood

135

1.85

2.21

1.2

—

(3007700) Barley IgE Ab [Units/volume] in Serum

2.04

2.20

1.1

1.0

17.1

u/ml

0.48

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

127

979

1.30

2.18

2.1

2.9

881.7

796.5

e6/l

0.62

401

(3016750) Collection duration of Urine

558

1.40

2.18

2.4

2.3

521.4

502.9

min

0.98

446

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

108

1.94

2.14

1.2

1.3

—

(44806071)

219

1.64

2.13

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

338

1.51

2.12

5.8

9.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

374

3231

1.16

2.12

2.0

1.8

—

(3024263) Appearance of Synovial fluid

553

1.39

2.11

2.2

1.8

—

(3014891) Appearance of Pleural fluid

102

1.96

2.09

2.0

1.7

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

221

1.63

2.07

1.1

—

(3004451) EKG impression Narrative

415

1.45

2.03

1.4

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

532

1.39

2.03

1.1

26.4

21.4

u/l

0.23

412

(3042111) Morphology [Interpretation] in Bone marrow Narrative

181

1472

1.23

2.02

1.7

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.96

1.99

1.2

5.0

5.5

mmol/l

0.13

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

122

949

1.29

1.99

1.7

1.5

29.8

34.8

0.77

584

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

749

1.32

1.98

1.0

1.1

97.8

93.2

0.99

607

(3000285) Sodium [Moles/volume] in Blood

119

1.85

1.96

1.3

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

704

0.68

1.94

1.1

1.2

—

(3024316) Viscosity of Plasma

2.35

1.94

1.1

1.4

1.9

1.5

mpas

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

202

1.63

1.94

2.2

6.0

7.9

mmol/l

3.43

112

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

257

1.56

1.93

1.3

1.2

773.0

337.2

pmol/l

0.48

189

(3003888) Timothy IgE Ab [Units/volume] in Serum

422

3706

1.14

1.93

1.1

5.9

6.5

u/ml

0.30

239

2031

(3035933) Granulocytes/100 leukocytes in Blood

487

1.40

1.92

2.8

1.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

330

1.49

1.92

1.3

1.6

11.0

8.8

ug/l

1.71

330

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

132

1044

1.27

1.90

1.1

1.2

1.0

1.1

ratio

0.88

378

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.05

1.90

2.3

1.9

50.8

43.6

umol/l

0.41

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

154

1241

1.24

1.89

1.7

1.6

55.0

53.2

0.20

105

782

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

128

1.80

1.88

1.0

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

195

1613

1.21

1.87

2.8

269.6

1003.2

u/ml

0.55

184

1461

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

151

1.72

1.85

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

277

0.50

1.84

1.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.20

1.83

1.0

0.0

0.1

u/ml

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

577

1.35

1.83

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

694

0.69

1.82

1.2

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

107

830

1.29

1.81

1.8

2.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

130

1.77

1.80

1.1

1.0

0.4

1.7

u/ml

0.54

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

101

1.88

1.80

1.2

1.6

6.3

17.0

pmol/l

1.21

(3012989) Citrate [Moles/time] in 24 hour Urine

3.04

1.79

2.0

1.5

1.8

2.1

mmol/24h

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

101

779

1.30

1.79

2.1

1.7

4.5

3.6

mg/l

0.73

743

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

185

1.62

1.74

5.7

5.2

28.6

39.0

ug/min

0.67

126

(3020491) Glucose [Moles/volume] in Blood

130

1041

1.25

1.72

1.7

1.8

6.3

6.1

mmol/l

0.35

106

809

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.67

1.72

1.0

1.3

4.3

1.6

mu/l

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.29

1.70

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

123

1532

0.80

1.70

1.8

1.6

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

2.00

1.69

1.1

1.4

42.0

27.7

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

535

1.35

1.67

1.1

88.6

84.5

u/l

0.12

427

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.24

1.63

1.0

0.0

0.1

u/ml

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

173

1.62

2.9

2.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

555

1.33

1.62

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

237

1.52

1.61

1.4

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

687

1.30

1.60

1.3

387.0

376.4

u/l

0.07

659

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

198

1.57

1.58

1.2

1.1

19.7

20.1

mmol/l

0.22

174

(3010144) Erythrocytes [#/volume] in Synovial fluid

114

910

1.25

1.58

1.4

169390.6

71019.4

e6/l

0.63

633

(3027540) Rickettsia typhi Ab [Titer] in Serum

2.69

1.58

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

397

3530

1.13

1.56

1.1

0.9

1.3

u/ml

1.14

189

1599

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

2.42

1.53

1.1

1.0

—

(40768800) Prostate Pathology biopsy report

116

1434

0.81

1.53

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

192

1.56

1.53

1.4

1.9

35.5

40.0

pmol/l

0.16

165

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

115

1.74

1.51

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

286

2495

1.15

1.51

1.2

—

(3045788) Cell count panel - Pleural fluid

713

1.28

1.48

1.7

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

376

1.38

1.46

1.9

2.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

155

1.61

1.45

1.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

867

9322

0.93

1.45

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

402

1.37

1.45

4.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

132

1.67

1.45

4.4

3.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

181

1530

1.18

1.45

1.3

25.6

33.9

u/l

0.72

162

1341

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

428

1.36

1.45

1.1

1.8

7.9

u/ml

1.57

319

(3016330) Potassium [Moles/time] in 24 hour Urine

195

1.54

1.44

1.5

1.3

—

89.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

365

3249

1.13

1.44

2.9

3.6

182.0

1853.8

u/ml

1.23

311

2787

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

708

1.27

1.43

2.3

2.8

41.9

41.4

0.09

250

(37021550) Renin [Units/volume] in Plasma --upright

244

1.48

1.43

1.5

1.4

62.8

101.6

mu/l

0.47

192

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

782

7234

1.08

1.42

2.4

2.8

37.0

41.0

u/ml

0.39

758

6977

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

156

1.60

1.42

1.0

1.3

33.8

61.5

—

(3004775) Volume in Urine collected for unspecified duration

736

1.26

1.41

2.4

2.3

611.2

643.0

0.38

533

(3020356) Listeria sp identified in Specimen by Organism specific culture

173

1.56

1.39

1.3

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.41

1.39

1.0

1.1

138.1

100.2

nmol/24h

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

111

1.71

1.38

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.61

1.36

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

485

1.32

1.36

2.3

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

485

1.32

1.36

2.3

1.7

—

(3045142) Bone marrow Pathology biopsy report

125

1028

1.22

1.36

1.3

1.4

—

(3026726) Creatinine [Moles/volume] in Specimen

1.83

1.35

3.2

2.2

496.3

458.8

umol/l

0.04

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

751

1.25

1.34

1.1

8.1

12.0

u/ml

0.50

147

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.87

1.33

3.0

3.9

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.13

1.33

1.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

168

1.55

1.30

1.0

0.2

1.3

u/ml

1.16

113

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.73

1.30

1.0

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

550

1.29

1.30

1.7

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

550

1.29

1.30

1.7

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

550

1.29

1.30

1.7

1.9

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

209

1.48

1.29

1.5

1.7

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.78

1.28

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

457

4155

1.10

1.26

1.1

1.8

u/ml

1.64

205

1764

(3022475) Manganese [Moles/volume] in Blood

1.74

1.24

1.2

1.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.40

1.24

2.5

5.1

—

(3046861) Legionella sp Ag [Presence] in Urine

2.22

1.24

1.6

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.22

1.24

1.1

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

171

1.52

1.22

4.6

6.7

69.1

70.3

0.08

138

(3036670) Protein [Mass/volume] in Synovial fluid

262

1.41

1.21

1.4

1.2

40.1

39.1

g/l

0.20

141

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

565

1.27

1.21

1.1

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.79

1.20

3.6

3.9

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

140

1.57

1.19

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

156

1.54

1.19

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.10

1.18

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

815

8698

0.93

1.17

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

391

3544

1.11

1.17

1.1

1.6

2.7

u/ml

1.40

105

946

(3017704) Immunofixation for Urine

419

1.31

1.16

1.2

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

813

8675

0.93

1.16

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

551

1.27

1.16

1.8

1.9

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

632

1.25

1.15

1.1

104.3

13.0

u/ml

0.42

388

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

977

9200

1.07

1.14

3.1

4.0

9.3

25.1

ug/l

2.21

748

7105

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

141

1197

1.18

1.14

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

283

1.38

1.13

1.7

52.1

31.9

u/l

0.22

258

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

216

1.44

1.12

2.6

2.8

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

816

8692

0.93

1.12

1.4

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

233

1.42

1.12

1.1

1.0

0.2

2.5

u/ml

0.81

127

(3002621) Streptococcal DNAse B [Units/volume] in Serum

167

1.50

1.11

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

327

2947

1.11

1.10

1.1

3.4

5.4

u/ml

1.12

137

1231

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.19

1.08

1.1

1.2

2.0

3.0

—

(3034426) Prothrombin time (PT)

522

1.26

1.07

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

813

8643

0.94

1.06

1.4

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

408

1.30

1.06

1.1

57.1

57.2

u/ml

0.00

398

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

194

1.44

1.06

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

419

1.29

1.03

1.9

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

419

1.29

1.03

1.9

2.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.06

1.02

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

146

1.51

1.02

1.4

1.6

—

(3022670) pH of Venous cord blood

1.83

1.02

1.1

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

223

2507

0.89

1.02

1.4

6.8

6.7

mmol/l

0.20

162

1799

(3020874) Milk IgE Ab [Units/volume] in Serum

149

1286

1.16

1.01

1.1

12.9

1.9

u/ml

0.61

395

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

816

1.20

1.01

1.7

1.9

2.8

2.1

u/field

0.36

377

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.69

1.01

1.0

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

213

1.41

1.01

1.2

1.4

28.2

23.3

0.38

195

(3023430) Cat dander IgE Ab [Units/volume] in Serum

304

2750

1.11

0.99

1.1

4.3

6.1

u/ml

1.23

138

1218

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.17

0.98

1.2

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

156

1.47

0.97

1.4

1.9

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.97

0.0

1.0

—

(4281824)

105

1241

0.84

0.97

1.1

1.2

—

(3035880) pH of Pleural fluid

423

1.28

0.97

1.1

1.3

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

140

1.50

0.96

1.0

0.2

2.0

u/ml

1.12

111

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.80

0.96

1.1

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

210

0.62

0.94

13.9

6.9

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

541

1.24

0.94

1.3

9.4

13.3

u/l

2.79

504

(3049233) Organic acids panel - Urine

1.89

0.94

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.89

0.94

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

133

1.50

0.93

5.0

3.2

—

(4211845)

697

1.21

0.92

3.0

2.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

427

1.26

0.91

1.9

2.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

886

0.82

0.91

3.0

3.1

—

(3017400) Magnesium [Moles/volume] in Urine

2.14

0.91

1.0

1.2

2.0

2.7

mmol/l

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

490

4554

1.08

0.89

1.6

3.7

6.1

iu/ml

0.20

108

941

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

447

1.25

0.89

3.8

3.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

467

1.24

0.86

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.67

0.84

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

370

1.27

0.84

1.1

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

286

0.70

0.84

1.5

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.93

0.84

1.2

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.93

0.84

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

162

1.42

0.83

1.2

1.3

—

(3003694) ABO and Rh group [Type] in Blood

4599

45092

1.03

0.82

1.6

1.7

—

(3013762) Body weight Measured

1.74

0.82

1.1

1.2

—

(40765096) Chromosome analysis panel by Banding

295

0.71

0.81

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

337

1.28

0.81

1.3

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

277

1.30

0.78

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

878

0.84

0.77

1.3

1.5

g/l

—

(3034614) HLA Ag [Interpretation]

1.76

0.76

1.0

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

322

2968

1.09

0.76

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

322

2968

1.09

0.76

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

393

0.76

0.75

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

392

0.76

0.74

6.4

6.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

194

1748

1.11

0.74

1.3

1.5

12.5

11.6

mmol/l

0.67

273

(44806420)

201

1.34

0.73

2.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.84

0.73

1.0

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

280

1.29

0.73

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

210

1.33

0.73

1.0

0.1

0.5

u/ml

1.42

118

(3050794) Legionella sp Ab [Presence] in Serum

106

0.57

0.72

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

825

0.85

0.69

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

195

1.33

0.68

1.9

1.6

7.3

262506.4

nmol/l

1.23

160

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

152

1.38

0.68

1.0

10.6

10.9

u/ml

0.03

108

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.53

0.68

1.4

336.2

307.6

umol/24h

0.20

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

204

1.32

0.68

1.1

—

(4133840)

386

0.78

0.68

1.3

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

259

2382

1.09

0.67

1.1

0.7

0.5

u/ml

0.25

537

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

231

1.30

0.67

1.0

0.3

0.9

u/ml

0.80

131

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.63

0.66

1.1

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

249

1.28

0.66

1.0

1.1

0.0

u/ml

0.65

149

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.59

0.65

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.61

0.64

1.1

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

116

1026

1.13

0.64

1.4

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

1.72

0.63

1.2

65.2

71.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

514

0.82

0.63

1.0

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.60

0.0

1.0

—

0.0

—

(4024509)

119

1062

1.12

0.58

1.7

1.5

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

201

1.29

0.58

2.7

3.6

26.4

22.6

mg/l

0.82

188

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.0

—

2.1

—

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.58

0.0

1.1

—

0.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.71

0.57

5.0

5.7

0.2

mmol/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

309

1.23

0.57

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

193

1.29

0.57

2.8

3.6

—

(40768795) Lymph node Pathology biopsy report

1082

0.89

0.56

1.3

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.58

0.54

1.0

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

240

1.25

0.53

1.0

0.4

0.2

u/ml

0.43

147

(3009871) Measles virus Ab [Titer] in Serum

502

0.84

0.53

1.6

1.7

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.43

0.52

7.0

5.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.43

0.52

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

196

1.28

0.52

1.2

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

214

1.26

0.52

1.5

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

232

1.25

0.52

1.2

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

251

1.23

0.50

1.1

0.5

2.2

u/ml

1.59

201

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.38

0.50

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

1.46

0.50

1.0

1.6

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.46

0.50

1.0

—

0.0

—

(3006462) Nitrate [Presence] in Urine

640

1.14

0.50

3.1

2.7

—

(4038314)

109

0.64

0.48

1.1

1.2

—

(3047189) Immunofixation for 24 hour Urine

372

1.18

0.48

1.5

1.7

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.40

0.48

1.4

1.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

180

1663

1.08

0.48

1.4

30.9

32.2

nmol/l

0.20

160

1544

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.45

0.48

1.0

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

102

1.37

0.47

3.1

3.5

2.9

1.2

mg/l

0.69

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

102

1.37

0.47

1.0

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

154

0.71

0.47

1.0

1.2

1.3

1.8

mmol/l

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.46

0.46

8.6

9.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

310

0.81

0.46

3.0

2.7

—

(3019174) dRVVT (LA screen)

155

1.29

0.46

1.2

—

(40762814) Titanium [Mass/volume] in Blood

120

1.33

0.46

2.2

2.3

3.7

4.2

ug/l

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.40

0.45

4.1

2.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

618

1.13

0.45

1.5

1.6

2.6

2.9

u/field

0.16

446

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

175

0.74

0.44

6.3

7.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

253

0.79

0.44

1.4

1.9

1.4

3.4

ug/l

—

152

(3024869) Neuronal Ab [Presence] in Serum

174

1.26

0.44

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.39

0.44

1.3

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

220

1.23

0.43

2.0

2.5

—

(4035726)

949

9204

1.03

0.42

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

151

0.73

0.42

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

357

3395

1.05

0.42

1.3

1.5

73.3

105.3

pmol/l

2.48

347

3296

(3051101) Glucose [Moles/volume] in Cord blood

139

0.72

0.42

5.7

6.2

—

(3011436) Histone Ab [Units/volume] in Serum

258

1.20

0.41

1.0

1.1

—

30.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.51

0.41

1.4

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

238

0.80

0.40

1.7

1.4

—

(3020650) Glucose [Presence] in Urine

409

0.85

0.38

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

206

1.21

0.37

1.3

1.2

195.7

298.1

ug/l

0.26

109

(3001893) Eosinophils/100 leukocytes in Pleural fluid

243

1.19

0.37

1.2

1.4

2.1

2.4

0.07

209

(3034891) Synovial lining cells/100 cells in Synovial fluid

496

1.13

0.36

1.6

1.5

2.5

4.4

1.19

120

(3001729) Color of Synovial fluid

0.65

0.35

3.2

1.5

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.43

0.35

1.3

1.1

161.8

241.9

nmol/l

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

375

1.15

0.35

1.7

1.6

—

571.9

iu/ml

—

(3032868) Hemoglobin electrophoresis panel in Blood

162

1.23

0.35

1.3

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

509

1.12

0.33

2.0

2.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

547

1.11

0.33

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

275

0.84

0.33

1.3

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

134

1250

1.07

0.32

1.0

1.1

16.5

2.8

u/ml

0.45

341

(3004959) Base excess in Arterial cord blood by calculation

155

1.23

0.32

1.1

1.0

-4.7

-1.9

mmol/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

665

6456

1.03

0.32

1.4

—

(40758292) HTLV I+II Ab panel - Serum

241

0.83

0.31

1.2

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

268

2559

1.05

0.30

4.4

3.2

20.4

25.4

mg/l

1.94

152

1574

(3029612) Listeria sp Ab [Titer] in Serum

1.32

0.30

1.1

1.4

—

(3006598) pH of Arterial cord blood

156

1.22

0.30

1.1

1.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

296

1.15

0.30

1.6

1.4

50.1

50.5

0.02

256

(42870560) Thyrotropin [Units/volume] in Cord blood

152

0.79

0.29

1.0

12.9

8.4

mu/l

1.29

130

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.25

0.29

3.9

5.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

841

1.08

0.29

1.1

1748.2

1470.4

miu/ml

1.50

841

(40768441) Liver Pathology biopsy report

890

1.08

0.28

1.2

1.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

251

1.15

0.28

1.6

1.3

40.0

38.6

0.07

170

(44786800) Granulocytes/100 leukocytes in Body fluid

1.28

0.28

1.2

1.3

39.9

26.2

0.56

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2099

21259

0.98

0.27

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

168

1.19

0.27

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

607

5909

1.03

0.26

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

328

1.13

0.26

1.2

1.1

—

(3005033) Fetal Nuchal fold Thickness US

681

6971

0.98

0.26

1.4

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

179

1703

1.05

0.25

3.1

3.7

26.0

27.4

u/ml

0.09

170

1650

(3043238) Trisomy 21 risk [Likelihood] in Fetus

699

7147

0.98

0.25

1.5

—

(46235168) Fasting glucose [Moles/volume] in Blood

159

0.82

0.24

1.1

1.2

6.1

7.2

mmol/l

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.74

0.24

1.0

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.28

0.24

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

590

1.08

0.23

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

227

1.14

0.23

1.2

1.5

13.3

13.1

g/l

0.03

173

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

136

0.81

0.23

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

285

1.12

0.22

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

285

1.12

0.22

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

285

1.12

0.22

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

285

1.12

0.22

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

125

1.20

0.22

1.3

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

602

1.08

0.22

6.9

6.3

1247.9

5633.5

u/ml

0.41

127

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

669

0.93

0.22

3.1

2.8

78.9

145.2

au/ml

—

102

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.22

0.22

1.2

3.4

—

(3033799) Differential panel - Peritoneal fluid

276

1.12

0.22

2.0

2.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

172

1.16

0.22

1.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.19

0.21

1.4

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

684

6977

0.98

0.21

1.4

1.5

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.21

0.0

1.9

—

9.5

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3044007) Cell count panel - Peritoneal fluid

250

1.12

0.19

1.8

2.2

—

(3015183) Erythrocyte sedimentation rate

857

0.94

0.18

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.17

0.17

38.4

8.1

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.15

0.17

1.1

1.2

0.0

0.1

mg/l

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

282

1.10

0.16

1.6

2.0

4179.3

12809.5

e6/l

0.62

155

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.77

0.15

1.0

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.20

0.15

1.0

1.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

643

1.06

0.15

1.0

6.0

8.9

u/ml

0.33

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

255

1.10

0.14

1.1

0.7

1.4

u/ml

0.52

202

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

631

6400

0.98

0.14

2.1

2.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

783

1.05

0.13

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

263

0.91

0.13

16.0

7.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

242

0.91

0.13

16.6

7.3

—

(3044009) aPTT.lupus sensitive (LA screen)

161

1.12

0.12

1.2

—

(3025577) Chromium [Mass/volume] in Blood

452

1.06

0.12

2.2

2.1

2.3

2.4

ug/l

0.11

381

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

416

0.94

0.12

2.1

3.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

464

1.06

0.11

2.0

1.8

66.0

152.9

au/ml

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

718

0.96

0.10

3.7

3.4

8.2

8.1

mg/l

0.02

569

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

819

0.96

0.10

5.2

6.9

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

183

1.09

0.10

1.5

1.4

27.0

23.6

0.17

152

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

197

0.91

0.10

1.1

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

130

1332

0.98

0.09

1.6

1.7

—

(3041672) Baker's yeast Ab [Presence] in Serum

113

0.88

0.08

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.82

0.08

1.0

1.3

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.82

0.08

1.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.83

0.07

1.2

1.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.86

0.07

1.0

1.1

—

4.1

—

(40768793) Breast Pathology biopsy report

276

2795

0.99

0.07

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

122

0.90

0.07

1.8

2.1

0.6

0.8

u/field

0.16

122

(21494434) Karyotype in Bone marrow

788

1.03

0.06

1.1

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

183

1800

1.02

0.06

2.4

3.5

402.8

444.6

u/ml

0.06

159

1655

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

232

0.95

0.05

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

797

0.98

0.05

1.7

2.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

594

1.03

0.05

2.1

2.2

9.4

9.5

mg/l

0.09

482

(3001019) Free T4 and TSH panel - Serum or Plasma

964

9593

1.00

0.04

1.7

1.6

—

(40765089) Chromosome analysis panel - Blood by G-banded

784

1.02

0.04

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

117

1155

1.01

0.03

1.0

1.1

0.2

1.0

u/ml

1.08

178

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

101

1022

0.99

0.02

1.3

1.5

5.6

5.3

mmol/l

1.04

975

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

105

1061

0.99

0.02

1.2

1.3

—

(40757373) Influenza virus identified in Isolate

208

0.96

0.02

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

939

1.01

0.02

1.9

1.8

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

123

1.06

0.01

1.9

3.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

567

0.99

0.01

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.06

0.00

9.0

4.5

—

(3048879) Bone marrow aspiration report

226

0.97

0.00

1.7

2.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

196

1.02

0.00

1.3

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

115

0.96

0.00

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

336

1.01

0.00

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

336

1.01

0.00

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

336

1.01

0.00

1.0

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

315

1.02

0.00

1.6

2.3

346.6

3353.6

e6/l

0.65

219

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

105

1050

1.00

0.00

1.4

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

934

1.01

0.00

1.2

1.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

195

1.02

0.00

1.1

1.5

34.5

25.0

g/l

—

147

(3016031) Almond IgE Ab [Units/volume] in Serum

171

0.99

0.00

1.0

1.1

0.3

0.8

u/ml

1.45

110

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.00

0.00

1.0

1.1

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.4

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.0

1.0

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.0

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.02

0.00

2.2

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.99

0.00

1.1

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.87

0.00

1.0

1.3

—

(3030703) Everolimus [Mass/volume] in Blood

0.00

0.0

17.3

—

5.8

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.0

1.7

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(40763527) Lymphocytes.vacuolated [Presence] in Blood by Light microscopy

0.00

0.0

1.2

—

0.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(4212803)

0.96

0.00

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_BEHAVE and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_BEHAVE	1.939 [1.69, 2.22]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.253

During the follow-up period (1.1.1998 — 31.12.2019), 3610 out of 54138 females with F5_BEHAVE died.

Males

Parameter	HR [95% CI]	p-value
F5_BEHAVE	2.219 [1.97, 2.5]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 4402 out of 31315 males with F5_BEHAVE died.

Mortality risk

Mortality risk for people of age

years, who have F5_BEHAVE.

N-year risk	Females	Males
1	0.206%	0.434%
5	1.168%	2.489%
10	2.808%	6.508%
15	5.371%	11.959%
20	9.394%	19.807%

Relationships between endpoints

↥

Index endpoint: F5_BEHAVE – Behavioural syndromes associated with physiological disturbances and physical factors

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Behavioural syndromes associated with physiological disturbances and physical factors

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints